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INTRODUCTION  
The most ancient and primordial medicine system is Siddha. Siddha is an 
orthodox and traditional medicine system which is been followed from past 25000 
years with paramount potential and capability of numerous Siddhars, on which the 
name Siddha Medicine has been initiated. Every Siddhar were possessed with ashta 
siddhi or eight supernatural powers. Father of Siddha Medicine is Agasthiar. There 
are 18 other Siddhars who has contributed their valuable knowledge and experiences 
in Siddha medicine. 
According to Siddha system human body consists of five elements such as 
Earth (Munn), Fire (Thee), Water (Neer), Air (Vayu) and Space (Agayam). Siddha 
medicines were conceived and constructed with assorted research and analysis carried 
on animals, herbs and minerals by the Siddhars. The main aim of Siddha medicine is 
not only to provide treatment for disease but also to prevent from the disease.This 
medicine has been carried out and followed by generations and generation in various 
Gurukuls and now days in educational institutions. 
 Initially this medicine was invented and practiced by the Dravidian civilization 
and thereafter the medicine was developed in Tamil language.Vata, Pitta and Kapha 
are the main three Doshas in Siddha medicine. It is been found that any kind of 
disturbance occurs in these humors will cause disease. The diseased body can be 
recovered with the help of the siddha medicine. Siddha medicine system contains both 
internal and external medicine. 
Siddhars had defined 4,448 types of disease. Vatha kalladaippu is one of them, 
this disease mostly affects male as compared to female
1
. Yugi in his“YUGI 
VAIDHYA CHINTHAMANI 800” explains about aetiology, pathology, 
classification, clinical features, and prognosis. Urinary system can be divided into two 
forms: 
“நீரினை அருக்கல் ந ோய் 
நீரினை பெருக்கல் ந ோய்” 
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Vatha kalladaippu comes under “நீரினை அருக்கல் ந ோய்” in which the output 
of urine level will be very low, which will dry the urine and form urinary calculi due 
to various aetiological factors. 
Urolithiasis is also known as Nephrolithiasis, which has been derived from the 
Greek word Nephros means kidney and Lithos means stone, kidney stone. 
Urolithiasis or Nephrolithias is is formation of urinary calculi at any level of 
the Urinary tract. It is characterized by acute loin pain radiating to groin, and it 
consists of aggregates of crystals containing small amount of proteins and 
glycoprotein. Though various kinds of stone have been identified, calcium stones are 
the most common in human as well as rats
2
.
 
Urinary  stone  disease  is  a  common  disorder  estimated  to  occur  in 
approximately 12%  of  the  world  population,  with  a  recurrence  rate  of   70-
81%  in  males  and  47-60% in females . The peak incidence is observed in 2
nd
 and 
3
rd
 decades of life
3
.
 
Stone disease is frequently a recurrent problem more than 50% of patients 
with the calculus will have formed a further stone or stones within ten years. Obesity, 
aging, dietary indiscretions, global warming are some of the elements which plays a 
vital role causing stone disease. The risk of recurrence increases if a metabolic or 
other abnormality predisposing to stone formation is present and is not modified by 
treatment 
4
. According to Siddha system of medicine Vatha kalladaippu occurs due to 
increase of Pitha. 
On the above theory, I selected Vatha kalladaippu as my dissertation topic 
because now days the prevalence is increasing due to change in the life style of people 
and environment, moreover people prefer Siddha medicines to remove stones instead 
of a surgery. In Siddha system there are many drugs available for Kalladaippu, but I 
chosen Kalladiappu Chooranam for my clinical study to prove the efficacy of my 
drugs, over the other drugs because each and every drug of has its diuretic activity as 
well as it is a combination of herbo mineral. Herbal medicine provides economically 
effective and time tested and the same is considered as safe when compared to 
Modern synthetic drugs.  
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Therefore I selected Vatha kalladaippu (Urolithiasis) as my dissertation 
topic to cure the disease without surgery. For which, I choose Kalladiappu 
Chooranam to study its effect on Vatha kalladaippu both pharmacologically as well as 
clinically. 
My clinical study is to observe the various factors in the evolution of Vatha 
kalladaippu and with the help of Siddha medicine, Kalladiappu Chooranam. 
AIM AND OBJECTIVES 
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AIM AND OBJECTIVES 
AIM: 
 The aim of my dissertation is to evaluate the efficacy of siddha drug 
Kalladaippu Chooranam both clinically and experimentally in the treatment of 
Vatha Kalladaippu (Urolithiasis). 
OBJECTIVES: 
 To collect the authorial measures and literature reviews of vatha kalladaippu 
noi in ancient siddha and modern literatures. 
 To have an idea of the incidence of the disease with regard to age, sex, 
occupation , socio economic status, food, climatic conditions and precipitating 
factors etc. 
 To expose the efficacy of siddhar’s diagnostic principles. 
 To utilize the possible moder  methods to confirm the diagnosis and prognosis. 
 To have clinical trial on patients with vatha kalladaippu noi with selected 
siddha medicine. 
  KalladaippuChooranam 
 To evaluate 
 Toxicological screening 
 Acute 
 Sub acute 
 Pharmacological screening 
 Lithotriptic activity 
 To find out the Physio chemical & Phyto chemical analysis  
  To find out the statistical analysis of clinical study 
REVIEW OF LITERATURE 
  
SIDDHA  ASPECT 
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SIDDHA  ASPECT 
 The diseases of the urinary system are divided into two types. They are  
“நீரினண  அருக்கல்   ந஢ோய் 
நீரினண   பதருக்கல்  ந஢ோய்
”5
 
The disease kalladaippu comes under the classification of “Neerinai Arukkal 
Noi”. In siddha system of medicine, the disease kalladaippu is mentioned by Yugi 
Munivar in Yugi Vaidhya Chinthamani 800. 
“நீரிரு வினணக்கு஠த்ன஡  நீ஦றி விரித்துச்  ப ோல்஬ோம் 
நீரினண  பதருக்கபனோன்நந  நீரினண  ஦ருக்க பனோன்று 
நீரிழிவுடநண  பகோல்லும்  நீர்க்கட்டு  வினணகபபோன்று”6 
   KALLADAIPPU  NOI 
VERUPEYAR (SYNONYMS) 
 Achmari 
IYAL (DEFINITION) 
 Sudden obstruction in the flow of urine, pain at the tip of the penis in males 
and clitoris in females, burning micturition, loin to groin pain, passing of small sand 
like stones along with urine are the cardinal features of this disease
7
. 
Dehydration occurs due to overheat of the body. It leads to solid or crystalline 
aggregation from the dietary minerals in the kidney. The formed stone cannot 
expelled  by kidney leads to this diseased condition
8
.  
 Large concentions of stone in the bladder or kidney are known as calculus or 
gravel. It is attended with difficulty in passing urine
9
.
                            
 
              Sudden obstruction to the flow of urine, pain at the tip of the penis in males 
and clitoris in females, burning micturition, pain in loin to groin region
10
. 
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            வினகு  சினந஢஧ம்  விடுதட்டு  நீந஧ோடும் 
 ஒழுகி஦ ஬ோயு ப஥ோதுகிணோல் ந஢ோகோது 
஬ழுகி஦ ஥ந்த்஡ோல்  ஬ோயு஬ந்ந஡ புகில் 
கழுவி முதிர்ந்திடும் கல்னனடப்தோகும்
11
.
 
 
஡ோணோண மூத்தி஧ப்னத ஡ன்னினப்தோ 
஡னி஦ோண கல்லிருந்஡ோல் ப ோல்னக் நகநப 
ஊணோண மூத்தி஧ந் ஡ோணடிக்கடிந஦ ஡ோனும் 
உள்பதடி இநங்கு஥டோ ப ோன்நணன் தோரு 
ந஡ணோண கல்னப்தோ ஡ோன஧ ந஥நன 
ப஡ோப்பதணந஬ விழு஬஡ோல் ஡ோன஧஦ப்தோ 
஥ோணோக விழு஬஡ணோநன நின்று நதோகும் 
஥க்களுக்கு இதுதீ஧  னோனக நதோநட 
 
  “஡ோபணன்ந மூத்தி஧த்஡ோல் ஢ந஢நப஬ன்று 
 ஡ங்கி஦ந஡ோர் பதோடிந஦னும் ஥஠ல்஡ோணப்தோ 
஬ோபணன்ந சிறி஦ப஡ோரு கல்னோ஬஡ப்தோ 
 ஬ப஥ோக ஬ந்துவிழும் ந஢ோய்க்குத் ஡ோநண 
஌பணன்று அச்஥ரீ ந஧ோகப஥ன்ந நத஧ோம் 
 ஡ோககல்லுகள் ஡ோன் விழுகும் நதோது 
நகோபணன்று குண்டிக்கோய் மூத்தி஧க் கு஫னப்தோ
 
  கு஠஥ோண மூத்தி஧ப்னத நீர்த்஡ோன஧க் நகநப 
நகபடோ முங்குறியில் ஋ரிச் ல் கண்டு 
பகோடி஦ோக ந஬஡னணகள் கோட்டு஥ப்தோ 
஬ோபடோ சிறி஦ப஡ோரு கற்கள் ஡ோநண 
஬ப஥ோண மூத்தி஧ப்னத கு஫ல்஬ழிப் தடி஦ோய்த் 
ந஡படோ ஬ரும்நதோது திந஧கந்஡ன்னில் 
ப஡ரிப்தது நதோன யிருந஬஡னண ப ய்யும்தோரு 
஢ோபடோ கற்கள் ஡ோனிநங்கி விட்டோல் 
  ஢ன஥ோண ந஬஡னணகள் தீரும்தோந஧
12” 
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Agasthiyar says the definition of Kallaidaippu as sand likes crystals deposited 
in urine, followed by small size of stones which is excreted in urine .Stones are 
stagnated in kidney, ureter, urinary bladder and urethra. Pain with burning sensation 
starts in urethral orifice followed by agonizing pain during the stone moving in 
urethral tract from the bladder , when the stone removed pain also relieved. 
NOI VARUM VAZHI (AETIOLOGY) 
“ப஡ளிந்஡ந஡ோர் கல்னனடப்பு ற்தத்தி நகபோய் 
சிறிது ஢ோட்டுடங்கிந஦ ந஥கந்஡ன்ணோல் 
஡ளிந்஡ந஡ோர்  னப்னதயிலுதி஧ந் ந஡ோய்ந்து 
 ந்து  ந்஡ோகந஬ தருத்துக் பகோள்ளும் 
஬ளிந்஡ந஡ோர் ஬ோ஡பித்஡ங் நகோபித்஡க்கோல் 
஬ந்து பதருங்கல்னோய் நீர்஬ழி஦னடத்து 
஢ளிந்஡ந஡ோர் ஢ோலுவி஡க் கல்னனடப்பு 
஢ண்தோண  ஬஧னோறு ஢ோட்டக்நகநப” 
கனங்கிணந஡ோர் ஡ண்ணீர்஡ோன் குடித்஡நதர்க்கும் 
கல்பனலும்பு ஥யிர் ஥ண்஡ோன் கனந்஡ன்ணத்தில் 
அனங்கிணந஡ோ ஧ன்ணங் கனருந்஡னோலும் 
அழுகநனோடு மூத்஡தண்ட ஥ருந்஡னோலும் 
஥னங்கிணந஡ோர் ஥ோப்தண்ட ஥ருந்஡னோலும் 
஥ந்஡த்தில் ஬ோய்஬ோண த஡ோர்த்஡ந் ஡ன்னண 
துனங்கிணந஡ோ ருசி஡ன்னிற் சுன஬த்஡னோலும் 
சுருக்கோய் கல்னனடப்பு ஬ந்து ந஡ோன்றுந்ந஡நண
13.” 
 The urine constituents will easily deposit on the urinary tract and form the 
stone. At that time by vitiation of vatham and pitham these small stone becomes 
larger in size and block the urinary passage. The semen will stagnate for a long time 
in the urinary tract, so it will obstruct the urine flow Urinary stone are also formed 
due to the drinking of contaminated hard water, taking of food mixed with sand and 
small stones consuming of contaminated food articles, food containing more 
carbohydrates, unhealthy food habits. 
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A urinary disease occasionally developed in the urinary bladder which is 
known as vesical calculus. It is said to be due to the deranged vayu encircling or 
prevailing in the region of the abdomen arising from any of the following causes. 
1) Suppression of seminal discharge during sexual intercourse. 
2) Retention of semen in the spermatic region in involuntary discharge 
during nocturnal emissions due to excessive heat in the body. 
           The calculus are stone which is formed in the bladder may vary in size from 
that of the particles of sand or mustard upto things as large as green gram or Bengal 
gram and sometimes attains the size of a hen’s egg even and block the passage of 
urine. It is accompanied by pain and difficulty in passing urine
14
. 
                             “நீரினணத் ஡டுத்஡ல்  ப ய்யின் 
      நீர்க்கட்டுத்  து஬ோ஧ம்  புண்஠ோம் 
                                         தோறிடு  ந்து  ந்தில் 
       தண்தந ந஢ோ஬஡ோகும் 
                                        ந஢ரினங் க஦ரும் கோமி஦ம் 
                                                   நிச் ஦ம் ந஢ோ஡ல் ப ய்யும் 
                                         தோரினி னதோண ஬ோயு 
       தண்புநச்    ந ரு஥ன்நந
15” 
POTHU KURIGUNANGAL(Clinical features) 
 Gradual or sudden obstruction of the urine flow. 
 Unbearable pain in the penis 
 Excruciating pain and swelling is experienced at the tip of penis if the calculus 
attempts to expel. 
 Colicky pain radiating from loin to groin, lower abdomen and urethra if the 
calculus is irregular with sharp projection.  
 Burning and scanty micturition and Haematuria16. 
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CLASSIFICATION
 
Classification according to yugi mamunivar,
 
“ந஡ோன்றிண஡ோர் ஢ோலினிட ஢ோ஥ங்நகபோய் 
  சுறுக்கோண ஬ோ஡த்தின் கல்னனடப்பு 
பூன்றி஦ந஡ோர் பித்஡த்தின் கல்னனடப்பு 
  பு஧ண்டந஡ோர் ந த்து஥த்தின் கல்னனடப்பு 
தீன்றி஦ந஡ோர் ப஡ோந்஡஥ோங் கல்னனடப்பு 
  ந஡கத்திற் தற்றிந஦ சிறிதுகோனம் 
஡ோன்றிந஦   னப்னதயில் ஬ந்திழிந்து 
   ருவிந஦ லிங்கத்திற்நரிக்குந் ஡ோநண
17”  
According to Yugivaidhyachinthamani, kalladaippu is classified into four types. 
1) Vatha kalladaippu 
2) Piththa kalladaippu 
3) Silethuma kalladaippu 
4) Thondha kalladaippu 
1)  Vatha kalladaippu: 
“஡ரித்து  ஢ோபிக்குங்  கீழ்சுருக்கோய்  குற்றில் 
   ன  ஥னந்஡ோன்  வி஫ோ஥ற்  நம்த஥ோகி 
஬ரித்துந஥ லிங்கத்தில் ஬லியு஥ோகி 
  ஥ருவி஦ந஡ோர் பதோத்திப஦னோஞ் சு஧ந்துகட்டி 
திரித்திந஦ கினடக்பகோடோப் பி஧ட்டனோகித் 
  ந஡ம்பிந஦ மூச்சு஥ோய் ஬யிறுமுப்பும் 
உரித்ந஡ோர்  ன஡நதோன உ஬ர்ப்பு஥ோகும் 
  ஓங்கி஦ந஡ோர் ஬ோ஡க்கல்னனடப்பு ஡ோநண
18.” 
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Acute pricking pain in the lower abdomen, scanty Micturition, obstruction to 
the flow of urine, pain in the penis, abdominal discomfort, and albuminuria will be 
present with mucous discharge and black coloured stone will be expelled. 
2)      Piththa kalladaippu: 
“அனடப்தோகிச்  னந்஡ோனு ஥ரு஬னோகி 
  அ஦ங்கோச்சி ப ோருகிணோற்நதோநன கோணும் 
புனடப்தோகிப் பதோற்றிப஦ங்கும் புழுக்க஥ோகிப் 
  பூட்டுநதோல் பிகு஬ோகிப் பி஧ட்டனோகும்  
஥னடப்த஥ோகி உதி஧நிந஥ோய்க் கல்னோகி 
  ஬ந்திழிந்து லிங்கத்தில் ஥ோட்டிக்பகோள்ளும் 
குனடப்தோகிக் குற்நனோய்க் கூச் னோகிக் 
  கு஡ட்டுந஥ பித்஡க்கல்னனடப்பு ஡ோநண
19.” 
Obstruction of urine flow, pricking pain and burning sensation in external 
meatus, expulsion of blood coloured stones. 
3) Silethuma kalladaippu: 
“஡ோணோண ப஡ோப்புளிநன வில்லு நதோனச் 
   லி஦ோ஥ற் சு஧ந்துந஥  ற்நந குற்றும் 
஌ணோண கோநனோடு னககள்  ந்து 
  இடுப்பு஡ோன் குனட னோ யிசிவு கோணும் 
ந஬ணோண லிங்கத்தின் ப஬ண்ன஥ ஡ன்னில் 
  விறுவிபநன்நந கடுப்தோகி வி஦ற்ன஬ ஦ோகும் 
ந஡ணோண ப஬ளுப்புக்கல் சிறு கல்னோகச் 
  சிக்கனோய் ஬ந்திநங்குச் ந ட்தந்஡ோநண
19” 
In this type of Kalladaippu the symptoms are, pricking pain in umbilicus, pain 
radiating towards thigh, pain in the joints of hands and legs, burning micturition 
excessive sweating, expulsion of white coloured stone in urine, excessive sweating. 
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4)  Thondha Kalladaippu: 
“஬ந்திநங்கும் நீர்஡ோன஧஦டி யிற்நோனும் 
  ஥ோ஬ருத்஡ முண்டோகி ஬லியு஥ோகி 
ப஢ோந்திநங்கி நீர்஡ோனு ஥ருவிதோயும் 
  ப஢ோய்஡ோண சிறு஥஠ல் நதோல் ப஢ோறுங்கிக்கல்னோன் 
 ந்திநங்கி நீர்஬ழியில் ஬ந்து விழும் 
  ஡ோக்கோண சிநங்னகக்கல் திணப஥ோன்றுக்கு 
துந்திநங்கித் திணந்திண முமி஫ந்துபகோல்லும் 
  ப஡ோந்஡஥ோங் கல்னனடப்புச் சூட்டிட்டோந஦
20” 
Severe pain in urethra, Dysuria, Oliguria, handful of small sand like stones 
will expel with severe pain. 
According to Dhanvanthri, 
“திருந்தி஦ ஬ோ஡பித்஡ச் சிநனற்தணம் பி஧நகோபித்஡ோல் 
஬குந்஡ க஥ரித்஡ோ ஢ோன்கு  ஬னகப்தடும் கல்னரிப்தோன் 
பிரிந்திடுஞ் சிநனற்தணோ க஥ரிபித்஡ோசு஥ரி பின்னு 
மிருந்திடு சுக்கினோசு஥ரி ஢ோன்கு ப஥ய்துப஥ன்நந
21” 
Achmari is classified into four types; 
1. Kallerippan 
2. Silethumaachmari 
3. Piththaachmari 
4. Sukkilachmari 
1)  Kallerippangunam: 
“சுத்துநீர் ஢ோலிந்஡ன்னிற் சுக்கினந்஡னிற் சிநனற்தம் 
பித்துமீ துனர்த்஡ல் கல்னோய்ப்பீ கி நீ஧னடத்துக் பகோள்ளுங் 
பகோத்துநீ ரிற்றுவிழுங் பகோப்புபந஢ோ குடம்புகோயுஞ் 
சித்஡஥ோ ஦ருசியுண்டோஞ் ந ர்ந்஡ கல்பனரிப்தணோந஥.
21
”
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 Increased iyyam and azhalkutram dries the urine and semen forming calculi. 
Formations of stones in the urinary tract, oliguria, pricking pain around the umbilicus, 
fever, anorexia are the symptoms of this type. 
2) Silethumaachmarigunam: 
நீர்஬ரு  ஢ோபந்஡ன்னில்  நின்றுநீர்  சிறுத்துக்பகோண்டு 
 ந ோர்஡ரும்  சி஬ப்புப஬ண்ன஥  சுக்கினம்  நதோனவீழூம் 
நதர்பதந  ஢ோனோப஥ட்டுப்  பின்ண஥ோய்க்  கல்லுவீழும் 
 ஌ர்பதறு  சிநனற்தணத்தில் அச் ஥ரி ஋ன்ணனோந஥
22” 
 
Calculus in the Ureter urethra causes hydronephrosis, oliguria, Reddish white 
in colour and falls out like semen and stones are expelled as 4 or 8 fragments. 
3) Piththaachmarigunam: 
“பதய்யும்  நீர்஢ோபந்஡ன்னில்  பித்஡த்஡ோ  பனரிப்பதழுந்து 
ப ய்யு வுஷ்஠த்஡ோல் ப஬ந்துந ங்பகோட்னடநதோற்கல்லுண்டோம் 
஢ய்஦ந஬  ஡னணகள்  ப ய்யும் ஢வில்கு஠ம்  பித்஡ந்஡ன்னில் 
஋ய்஡சு஥ரி  ப஦ன்நநமுன்  னி஦ம்பிண஧  றிவின்மிக்நகோர்
22.” 
Burning sensation in urethra due to Azhal Kutram, burning micturition and 
formation of stone that appear like semicarpusanacardium seed. 
4) Sukkilachmarigunam: 
“சுக்கினம் ஬ருங்கோனத்தில் ஡ம்பித்஡ோற் சுக்கினந்஡ோன் 
மிக்ககல்னோகி ப஬ம்பி வி஡ண஥ோய் நீர்விடோ஥ற் 
சிக்கி நீர் வி஫ோ஥னங்நக ஥஠ல்வீழும் ப஬ளுக்குந்ந஡கம் 
மிக்கு஠ ஞ்சுக்கினோசு ஥ரி஦  ோத்தி஦ப஥ன்நநோந஡
23” 
Suppression of semen, develops on two stones and obstruction in the flow of 
urine, sand like gravels are expelled, pallor of the body and this is incurable. 
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SAATHIYAM, ASAATHIYAM (PROGNOSIS) 
As per yugi, Vatha kalladaippu, piththa kalladaippu, silethuma kalladaippu are 
curable. Thondha kalladaippu is fatal. 
“சூட்டி஦  ோத்தி஦த்ன஡ச் ப ோல்னக் நகபோய் 
சுளுக்கோகும் ஬ோ஡த்தின் கல்னனடப்பு 
பூட்டிட்ட பித்஡த்தின் கல்னனடப்பு 
புக஫ோண ந ட்டு஥த்தின் கல்னனடப்பு 
மூட்டிட்ட இதுமூன்று ஥ ோதி஦஥ோகி  
முனண஦ோண ஥ருந்துகளிற் ப ம்ன஥஦ோகும் 
ந஡ோட்டிட்ட ப஡ோந்஡஥ோங் கல்னனடப்புத் 
ப஡ோடுசுநந஬ பகோல்லுமிது சூட் ந்஡ோநண
24.” 
 
MUKKUTRA VAERUPADUGAL (PATHOGENESIS): 
 Disease occurs due to the derangement in 
 Uyirthathukkal 
 Udalthathukkal 
 Kallamarupadu (seasonal changes) 
 Thinai (living lands) and 
 Udalvanmai. 
Mukkutraiyal: 
 The function of the three uyirthathus: 
a) Vali – Kattru + Veli 
b) Azhal – Thee  
c) Iyyam – Neer + Mann 
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The alteration of three thathu in their reaction to extrinsic or intrinsic factors 
results in disharmony. This altered harmony and balance variation of the three thathus 
results in disease. Their natural ratio (1:1/2:1/4) to each other is discerned by the 
physician at the wrist and each nadi is individually assessed for its strength, speed and 
regularit. 
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VATHAM 
 The term vatham denotes vayu, dryness, pain and flatulence. Based on 
functions and locations it is classified into ten types. They are tabulated below. 
S.No Vatham General Features 
Changes in 
VathaKalladaippu 
1 Piranan 
(Uyirkkaal) 
Responsible for respiration and it is 
necessary for proper digestion. 
Normal 
2 Abanan 
(Keel 
nokkukkaal) 
Responsible for all the downward 
forces such as voiding of urine, 
stools, semen, menstrual flow. 
Affected 
(Scanty     
Micturition) 
3 Viyanan 
(Paravukaal) 
Dwells in the skin and is concerned 
with the sense of touch, extension 
and flexion of the parts of the body 
and distribution of the nutrients to 
various parts of the body. 
Normal 
4 Uthanan 
(Melnokkukaal) 
Responsible for all kinds of upward 
motion such as nausea, vomiting etc., 
Affected 
 (Nausea, 
vomiting) 
5 Samanan 
(Nadukkaal) 
Considered essential for proper 
digestion, assimilation and carries the 
digested nutrients to each and every 
organ. 
Affected 
6 Nagan Helps in opening and closing of 
eyelids. 
Normal 
7 Koorman Responsible for vision, lacrimation 
and yawning. 
Normal 
8 Kirugaran Induces appetite, salivation, all 
secretions in the body including nasal 
secretion and sneezing. 
Normal 
9 Thevathaththan Induces and stimulates a person to 
become alert, get anger, to quarrel, to 
sleep etc., 
Normal 
10 Dhananjeyan Resides in the cranium and produces 
bloating of the body after death. This 
leaves from the body after 3 days of 
death, forming a way through the 
skull
25
 
Normal 
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PITHAM 
 It is the thermal life force of the body. It is sub divided into five types. They 
are 
 
S.No 
 
Pitham 
 
General Features 
Changes in 
VathaKalladaippu 
1 Anarpitham Peps up the appetite and aids in 
digestion. 
Normal 
2 Ranjagapitham Responsible for the colour and 
contents of blood. 
Normal 
3 Saathagapitham Controls the whole body and is held 
responsible for fulfilling a purpose. 
Affected 
(Dysuria, Oliguria) 
4 Pirasagapitham Dwells in the skin and concerned with 
the shine, glow, texture and its 
complexion. 
Normal 
5 Alosagapitham Responsible for the perception of 
vision
26
. 
Normal 
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KABHAM 
 It is responsible for the stream line functions of the body and maintains body’s 
defence mechanism intact. It is again classified into 5 types. 
 
S.No 
 
KABHAM 
 
GENERAL FEATURES 
CHANGES IN 
VATHA 
KALLADAIPPU 
1 Avalambagam Lies in the respiratory organs, 
exercises authority over other 
kabhas and control the heart and 
circulatory system. 
Normal 
2 Kilethagam Found in stomach as it seat, 
moistens the food, softens and 
helps to be digested. 
Normal 
3 Pothagam Responsible for the perception of 
taste 
Normal 
4 Tharpagam Presents in the head and is 
responsible for the coolness of the 
eyes, sometimes may be referred to 
as cerebrospinal fluid. 
Normal 
5 Santhigam Necessary for the lubrication and 
the free movements of joints
27.
 
Normal 
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PARUVAKALAM 
S.No Perum Pozhuthugal Mukkutra Marupaadugal 
1 Kaarkaalam 
(Aavani & Purattasi) 
Mid August to Mid October 
VATHAM - Vaetrunilaivalarchi 
PITHAM – Thannilaivalarchi 
2 Koothirkaalam 
(Iypasi & Karthigai) 
Mid October to Mid December 
VATHAM – Thannilaiadaidhal 
PITHAM - Vaetrunilaivalarchi 
3 Munpanikaalam 
(Margazhi & Thai) 
Mid December to Mid February 
PITHAM – Thannilaiadaidhal 
4 Pinpanikaalam 
(Masi & Panguni) 
Mid February to Mid June 
KABHAM – Thannilaivalarchi 
5 Elavenirkaalam 
(Chithirai & Vaikaasi) 
Mid April to Mid June 
KABHAM – Vaetrunilaivalarchi 
6 Mudhuvenirkaalam 
(Aani & Aadi) 
Mid June to Mid August 
VATHAM – Thannilaivalarchi 
KABHAM – Thannilai adaidhal28 
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THINAI (LAND) 
 Siddhars classified the lands into five types. They are  
1. Kurunji – Mountain range 
2. Mullai – Pastoral area of the forest 
3. Marudham – The fertile river bed 
4. Neidhal – The coastal region 
5. Paalai – Arid desert 
Kabha diseases will occur in Kurinji land. Pitha diseases occur in Mullai land. 
Vatha diseases occur in Neidhal land. Staying in Paalai land is not good to health. 
Marudham land is the fertile area where no disease occurs. So, Marudham land is the 
best one to stay.The winter season gives good health to the man, early summer and 
later rainy gives moderate health. Whereas early rainy and later summer are more 
prone to diseases, that’s why siddhars called it as AanagaKaalam29.  
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RELATION BETWEEN MUKKUTRAM, KAALANGAL AND THINAIGAL 
 
 
Mukkutram 
Paruvakaalam (Seasons)  
Thinai Thannilaivalarchi 
(Accumulation) 
Vaetrunilaivalarc
hi (Aggravation) 
Thannilaiadaidhal 
(Alleviation) 
VATHAM Mudhuvenilkaalam Kaarkaalam KoothirKaalam Vatha 
disease 
is more 
prevale
nt in 
Neidhal 
land. 
PITHAM Kaarkaalam Koothirkaalam MunpaniKaalam Pitha 
disease 
is more 
prevale
nt in 
Mullai 
land. 
KABHAM Pinpanikaalam Elavenilkaalam Mudhuvenil 
Kaalam
30 
Kabha 
disease 
is more 
prevale
nt in 
Kurunji 
land
31
.
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UDAL VANMAI (IMMUNITY) 
 Siddhars classify udalvanmai into three types. They are 
1. IyarkaiVanmai 
2. Kala Vanmai 
3. SeyarkaiVanmai 
UDAL KATTUGAL 
S.No Udalkattugal General Features Changes in 
Kalladaippu 
1 Saaram 
 (Digestive essence) 
Responsible for the growth and 
development. It keeps the 
individual in good temperament 
and it enriches the body. 
Affected due 
to pain 
2 Senneer (Blood) Responsible for the color of the 
blood and for the intellect, 
nourishment, strength of the 
body. 
Normal 
3 Oon (Muscle) Gives lookable contour to the 
body as needed for the physical 
activity. It feed the fat next day 
and gives a sort of plumpness to 
the body. 
Normal 
4 Kozhuppu (Fat) Lubricates the organs to facilitate 
frictionless functions. 
Normal 
5 Enbu (Bones) Supports and protects the vital 
organs, gives the definite 
structure of the body and 
responsible for the posture and 
movements of the body. 
Normal 
6 Moolai (Bone marrow) Nourishes the bone marrow and 
brain which is the centre that 
controls other system of body. 
Normal 
7 Sukkilam/Suronitham Responsible for reproduction
32
. Normal 
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PINIYARI MURAIMAI (DIAGNOSIS) 
   Four steps are followed in diagnosing the disease. They are 
1. PoriyaalAridhal 
2. PulanalAridhal 
3. Vinaadhal 
4. Envagaithervugal 
PORIYAAL ARIDHAL PULANAL ARIDHAL: 
 In this, the physician should carefully observe the changes that occur in the 
five sensory organs (porigal) of the patient.PulanalAridhal are understanding by the 
sense objects. These are as follows: 
1. Mei   : Ooru     ( Somatic sense) 
2. Vaai  :  Suvai    ( Taste) 
3. Kan             :  Oli        (Vision) 
4. Mookku :  Natram ( Smell) 
5. Sevi  :  Oosai   (Sound) 
VINAADHAL( INTERROGATION): 
 An effective history taking helps one to diagnosis properly. By Vinadhal the 
physician should interrogate about the patients name, age, occupation, socio- 
economic status, food habits, history of past illness, history of present illness, family 
history, marital status, menstrual history and frequency of pain. 
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ENVAGAI THERVUGAL: 
  “஢ோடிப்தரி ம் ஢ோநிநம் ப஥ோழிவிழி 
஥னம் மூத்தி஧மின஬ ஥ருத்து஬஧ோயு஡ம்
33.” 
Nowadays advanced diagnostic tools have been developed by modern bio 
medical scientists. But siddhars have given eight diagnostic methodological tools. 
They are called as Envagaithervu.
 
Eight fold system of clinical assessments: 
 Siddhars have given eight diagnostic methodological tools. They are 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
8. Moothiram34 
GENERAL FINDINGS: 
NAADI: 
The word pulse means the beating of artery felt with the tip of the fingers; its 
rate and character go to indicate a person’s condition of health. It is also understood as 
the beating,throbbing or rhythmical dilatation of arteries as the blood is propelled 
along them by the concentration of the heart in the living body. The term pulse in 
medical practice is usually applied to beat or throb felt in radial artery at the wrist; 
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through it may felt over the temporal, carotid, ulnar, brachial, femoral and other 
artery. 
                      Normally the pulse is recorded in the radial artery in the right hand for 
the male and left hand for the female by keeping the index finger,the middle finger 
and the ring finger on it after gently scrubbing the area .It is one unit in vali as felt by 
index finger and a half unit in azhal as felt by the middle finger and one fourth units in 
iyyaas  felt  by the ring finger . 
Three humoursVatham, Pitham, and Kabham are in the ratio 1:1/2:1/4 
normally. Derangement in these ratio leads to various disease conditions. 
Naadinadai in kalladaippu 
 When the vatham add with mandham it produces the kalladaippu disease. 
“஌஬னோய்  கு஫னோய் பித்஡ஞ் ப ய்கு஠ம்  விபம்தக்நகபோய் 
நகோனந஬ல் விழி சி஬ந்து குளிர்ந்திடிரிருக்கு ஥ல்னோல் 
சீனந஬ நீர்கடுத்து ப஢ோந்து சுறுக்பகணச் சி஬ந்து வீழும் 
ஞனந஥ கிறுகிபநன்று ஢ோவுனர்ந் திருக்குங் கோ஠
35” 
SPARISAM: 
 By sparisam, the temperature of skin (thatpam- cold or veppam – heat), 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal growth 
of organs and tenderness can be felt. 
 InVathaKalladaippu, patient feels tenderness over the lower abdomen, renal 
angle and lumbar region. Also patient’s temperature is increased in lower abdomen, 
sweating all over the body at the time of colic.  
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NAA:- 
 By the examination of the tongue its colour, size, shape, coatings, moisture, 
movement, ulcer, fissures, crust and conditions of teeth and gums can be examined. In 
kalladaippu, the naa is not affected. 
NIRAM: 
 The colour of the skin all over the body a local region of affection in 
conjunctiva, tongue, nail bed and hair etc. 
   ValiUdal   :  Black colour 
   AzhalUdal : Yelllow or Red Colour 
   IyyaUdal  :  White or Yellow 
 In VathaKalladaippu, the Niramof Udal depends upon the body 
constitution, pallor of the body is absorbed  in sukkilaachmari. 
MOZHI: 
 By examining Mozhi (Speech), characters, hoarseness, slurring speech, 
various disorders of speech such as dysarthria can be noted. 
 In VathaKalladaippu there is a low pitch voice due to agonizing pain in lower 
abdomen and burning sensation. 
VIZHI: 
 Character of the eye is noted. Colour, warm, burning sensation, irritation, 
visual perception are generally noted. 
 In kalladaippu, the vizhi may be affected. Redness due to renal colic pain. 
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MALAM: 
 The stools are examined for quantity, hardening (malakattu), loose motion 
(bedhi), colour and smell. 
 In kalladaippu, the malam will be affected due to either constipation or 
diarrhoea. 
MOOTHIRAM 
a) NEERKURI (Urine examination) 
 Urine examination is good diagnostic method compare to naadi and 
other Envagaithervugal. Theraiyar mention it as. 
“அருந்து ஥ோறி ஧஡மும் அவிந஧ோ஡஥஥ோய் 
அக்கல் அனர்஡ல் அகோனவூன் ஡விர்஡஫ற் 
குற்நப஬ருந்தி உநங்கி ன஬கனந 
ஆடிக்கன த் ஡ோவிந஦ கோதுபதய் 
ப஡ோருமுகூர்த்஡க் கனனக்குட்தட்டு நீரின் 
நிநக்குறி ப஢ய்குறி நிருமித்஡ல் கடநண
36.” 
Siruneer should be collected in early morning; patient should be eating six 
tastes of food with regular time and well sleeping over night, urine should be examine 
within 3 hours. 
SIRUNEERIN POTHU GUNAM: 
  “஬ந்஡ நீர்க்கரி ஋னட ஥஠ம் நுன஧ ஋ஞ் பனண 
னநந்தி஦லுபன஬ ஦னநகுது முனநந஦
36.” 
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               The urine is examined for its Niram (colour), Eadai (Specific gravity), Nurai 
(Froth), Natram (Smell), Enjal (Deposits). Invathakalladaippu, the moothiram is 
affected due to scanty Micturition. 
NIRAM (COLOUR) 
  “பீ஡ம் ப ம்ன஥னதங் கருன஥ ப஬ண்ன஥ப஦ன் 
நநோன஡ங் பகோழுன஥ன஦ ப஦ோத்துகு நீந஧
37.” 
1. Yellow 
2. Red 
3. Green 
4. Black 
5. White  
KALLADAIPPU NEERIN GUNAM (COLOUR INDICATING URINARY 
STONES) 
 The urine colour would look like flesh washing water; this is indicated in 
kidney diseases. This is mentioned as 
“தீப்புனோல் கழுநீர்ச் ப ஦பனனிர் குண்டிக் 
கோய்த்துர்ப் தனத்஡ோல் கதித்஡ நீ஧ோ஥த் 
துர்ப்தனக் கதமும் ந ோரியும் பகோதிப்புநகப் 
தற்தகனோகப் னத஦ப் ததிந்ந஡
38.” 
EADAI (SPECIFIC GRAVITY) 
 Urine, not thick is considerably healthy. This is mentioned as 
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“மிகத் ஡டிப்பும் மிகத் ந஡நலும் இன்பநனில் 
சுகத்ன஡த் ஡ரும் ப஥ய்ச் சுதோ஬ நீர்஢ன்நந
39.” 
NURAI (FROTH) 
 Urine may be frothy in nature, if it is reduced in vali, azhal and ayyam are said 
to be deranged. This is mentioned as 
“தந்஡ ப஥ய்ப்தன  யிபகப்தடும் தரு஬த் 
஡ந்஡ர்ப் பூ஡஥ோய் அனின மூத்தி஧த்தில் 
 ம்தத்஡ப்தடும் ஡திநுன஧ப் புணநன
40.” 
NAATRAM (SMELL) 
 Foul odour with pyuria is observed in patients with urinary lithiasis associated 
with urinary tract infection and ulcer. This is mentioned as 
“ஓ஡஥஠த்ந஡ோ ட஬ந஬ோ஡ ப஥ோத்தி நங்கும் 
சீ஡பத்஡ோற் கம்மி஦ ந஡கிகளுக்நக 
கோணிதின சீழுற் கனந்திழி ஥஠முறின் 
கருப்த஢ோ பிகளுங் கோ஥஢ோப த்துளும் 
வி஧஠முண் டின்நநல் ஋ய்து ஥ோசு஥ரி஦ல் 
திருத்஡நன திண்஠ ப஥ண஥ணத் துன்நண
39.” 
ENJAL (DEPOSITS) 
 If urine excretion look like curd water white colour and sand like deposits in 
urine indicate stones in kidney. This is mentioned as 
“஢ோர்த்தி நீர்ப்தோல் நதோன ஢ணவுற்நங் கிழியு ஥ோணோல் 
஥ோ஧ற்த முற்ந நீரி னடி ஥ண்டிக் கிடந்஡ ஡ோணோல் 
தோரிந்஡ ப஥ழுகு ஥ோங்கோய் தற்றி஦ கல்வி ணோநன 
சீருற்ந ப ய்னக ப஦ன்று ப஡ரிவுநச் ப ப்தனோந஥
41.” 
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NEIKURI
 
 The early morning urine of the patient is analyzed by dropping a drop of 
gingely oil on the surface of the urine sample. The accumulation, formations, changes, 
and dispersal under the sunlight without any external disturbances of the urine sample 
can be noted. 
The urine kept on the kidney tray in sun light, on non wind condition, should 
be by dropping a drop of gin oil gently with rod. If oil spread like snake, it indicates 
valineer; a ring indicates azhalneer and float like a pearl indicates iyyaneer and sinks 
in urine indicates mukkutram. 
“அ஧ப஬ண நீண்டிணஃந஡ ஬ோ஡ம் 
ஆழி நதோல் த஧வின் அஃந஡ பித்஡ம் 
முத்ப஡ோத்து நிற்கின் ப஥ோழி஬ப஡ன் கதந஥
42”. 
 Vathaneer – The oil spreads like snake 
 Pithaneer – The oil spreads like ring 
 Kabhaneer – The oil spreads like pearl 
 If the oil spreads gradually, it indicates good prognosis43 
 If the oil spreads fast or gets mixed completely with urine or sinks in urine, it 
suggests bad prognosis. 
 Since kalladaippu is due to the derangement of vatham and pitham, the 
Neikuri will be vatha or pithaneer.   
MARUTHUVAM (LINE OF TREATMENT) 
 The entire siddha system of medicine consists of three great subdivisions 
namely, 
1) Noyillaneri (preventive) – Kaappu 
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2) Noineekuneri (curative methods) – Neekkam 
3) Uramaakkumurai (strengthening methods) - Niraippu . 
Noyillaneri is the special approach of the siddha system where regular dietary habits, 
early rising, physical and mental discipilinaries are all emphasized. Prevention can 
mostly save our body and soul, but modernization results in alteration of good health, 
leads to disease.  
Siddha system is playing major role in treating and preventing many chronic 
diseases. Likewise, herbal medicines have several phyto chemicals which exert their 
beneficial effect on urolithiasis by multiple mechanisms like, 
 Diuretic activity 
 Crystallization inhibiting activity 
 Anti-Litiatic activity 
 Antimicrobial activity 
 Analgesic and anti inflammatory activity 
 Improving renal function 
 Regulates oxalate, calcium mechanisms. 
          The main object of treatment is to bring down the deranged mukkutrams to 
natural equilibrium by giving purgatives, which cure derangement of vatham; this is 
one of the causes forVathakalladaippu. 
 In Siddha system, treatment is not only removable of disease but also the 
prevention and improving the body condition after removal of disease. This is said as 
kappu, neekkam and niraippu. 
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Fomentation: 
 An attack of renal colic may be aborted by the application of heat fomentation 
(hot water bottle or heater) to the lumbar region. Immediate treatment of loin pain or 
renal colic is bed rest. 
PREVENTION: 
1. For prophylactic purpose it is necessary to eliminate all hindrances to a free 
drainage of urine (constriction, adenoma of the prostrate etc) and to remove 
foci of infection from the teeth and tonsils. 
2. To prevent the formation of urate calculi, a diet of milk and vegetables and 
mineral water is prescribed. 
 In the presence of oxalate calculi restrictions are imposed on foods rich in 
calcium (milk, raw eggs, potatoes) with total abstinence from chocolate, 
spinach gooseberries and carrots. 
3. A patient with phosphorus, carbonate stones is kept on a meat diet and much 
water to drink. 
ADVICE: 
1. Patients should drink large amount of water (2 - 3 lit/day) 
2. Patient should not suppress the excretion of urine and seminal fluid. 
3. Preparation containing Vit. D must be avoided. 
4. Regarding prevention Anubhavavaidhya deva ragasiyam states that one should 
not suppress the excretion of Moothiram (urine) and Sukkilam (Seminal fluid). 
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NOI KANIPPU VIVATHAM (DIFFERENTIAL DIAGNOSIS) 
1) Neerkattu (Anuria) 
2) Neerchurukku (Oliguria) 
3) Chottuneer (Incontinence) 
DO’S AND DONT’S: 
DO’S: 
1) Drink 2-3 litres of water per day. 
2) Dring tender coconut, barley water, lemon juice, raddish juice. 
3) The following vegetables can be taken in the diet 
Raddish 
Lady’s finger 
Plantain pith 
Mint leaves 
Bottle guard 
DONT’S: 
1) Avoid cabbage, cauliflower, and tomato seeds, mushroom. 
2) Avoid milk and its products. 
3) Avoid chicken, fish and other sea foods 
  
MODERN ASPECT 
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MODERN ASPECT 
ANATOMY AND PHYSIOLOGY OF THE URINARY SYSTEM 
KIDNEYS 
 The kidneys are a pair of excretory organs situated on the posterior abdominal 
wall, one on each side of the vertebral column, behind the peritoneum. They remove 
waste products of metabolism and excess of water and salts from the blood, and 
maintain its pH. 
 
LOCATION   
The kindney is occupying the epigastric, hypochondrium, lumbar and 
umbilical and Vertically they extends from the upper border of T 12 Vertebra to the 
centre of the body of  L3 Vertebra. 
             The right kidney is slightly lower than the left kidney. And  the left kidney is 
little nearer to the median plane than the right . The transpyloric  planepassess through 
the upper part of the  Hilum of  right kidney and the lower part of the hilum of Left 
kidney. 
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SHAPE, SIZE, WEIGHT AND ORIENTATION 
 Each kidney is about 11cm long, 6 cm broad and 3 cm thick. The left kidney is 
a little longer and narrower than the right kidney. On an average the kidney weighs 
150 g in males and 135 g in females. The kidneys are reddish brown in colour. 
 The long axis of the kidney is directed downwards and laterally, so that the 
upper poles are nearer to the median plane than the lower poles. The transverse axis is 
directed laterally and backwards. 
EXTERNAL FEATURES 
 Each kidney is bean shaped. Each kidney has following features. It has 
                   2 poles    (upper and lower) 
                   2 borders   (medial and lateral) 
                   2 surfaces (anterior and posterior) 
TWO POLES OF THE KIDNEY 
 The upper pole is broad and is in close contact with the corresponding 
suprarenal gland. 
 The lower pole is pointed. 
TWO SURFACES 
 The anterior surface is said to be irregular and the posterior surface flat, but it 
is often difficult to recognize the anterior and posterior aspects of the kidney by 
looking at the surfaces. The proper way to do this is to examine the structures present 
in the hilum as described below. 
 
 
 
REVIEW OF LITERATURE  
 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 35 
 
TWO BORDERS 
 The lateral border is convex. The medial border is concave. Its middle part 
shows a depression, the hilus or hilum. 
HILUM 
 The following structures are seen in the hilum from anterior to posterior side: 
1) The renal vein 2) the renal artery and 3) the renal pelvis, which is the expanded 
upper end of the ureter. Examination of these structures enables the anterior and 
posterior aspects of the kidney to be distinguished from each other. As the pelvis is 
continuous, inferiorly, with the ureter the superior and inferior poles of the kidney can 
also be distinguished by examine the hilum. So it is possible to determine the side to 
which a kidney belongs by examining the structures in the hilum. Commonly, one of 
the branches of the renal artery enters the hilum behind the renal pelvis, and a 
tributary of the renal vein may be found in the same plane. 
CAPSULES OR COVERINGS OF KIDNEY 
1. The fibrous capsule: This is a thin membrane which closely invests the 
kidney and lines the renal sinus.  
2. Perirenal or perinephric fat: This is a layer of adipose tissue lying outside 
the fibrous capsule. It is thickest at the borders of the kidney and fills up the 
extra space in the renal sinus. 
3. Renal fascia: This is a fibroareolar sheath which surrounds the kidney and the 
perirenal fat called as the fascia of Gerota. It consists of an anterior layer or 
fascia of Toldt and a posterior layer or fascia of Zuckerkandl. 
4. Pararenal or paranephric body (fat): It consists of a variable amount of fat 
lying outside the renal fascia. It is more abundant posteriorly and towards the 
lower pole of the kidney. It fills up the paravertebral gutter and forms a 
cushion for the kidney. 
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Naked eye examination of a coronal section of the kidney shows: a) an outer, 
reddish brown cortex; b) an inner, pale medulla; c) a space, the renal sinus. 
The renal medulla is made up of about 10 conical masses, called the renal 
pyramids. Their apices form the renal papillae which indent the minor calices. 
 The renal cortex is divisible into two parts: a) cortical arches or cortical 
lobules, which form caps over the bases of the pyramids; and b) renal columns, which 
dip in between the pyramids. Each pyramid along with the overlying cortical arch 
forms a lobe of the kidney. 
 The renal sinus is a space that extends into the kidney from the hilus. It 
contains a) branches of the renal artery; b) tributaries of the renal vein; and c) the 
renal pelvis. The pelvis divides into 2 to 3 major calices, and these in their turn divide 
into 7 to 13 minor calices. Each minor calyx ends in an expansion which is indented 
by one or three renal papillae. 
 Histologically, each kidney is composed of one to three million uriniferous 
tubules. Each tubule consists of two parts which are embryologically distinct from 
each other. These are as follows. 
A) The secretory part, called the nephron, which elaborates urine. Nephron is 
the functional unit of kidney and comprises the renal corpuscle or Malphigian 
corpuscle and the renal tubule. 
B) The collecting tubule begins as a junctional tubule from the distal convoluted 
tubule. Many tubules unite together to form the ducts of Bellini which open 
into minor calices through the renal papillae. 
C) Juxtaglomerular apparatus is formed at the vascular pole of glomerulus 
which is intimately related to its own ascending limb of the Henle’s loop near 
the distal convoluted tubule. 
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BLOOD SUPPLY 
Usually there is one renal artery on each side, arising from the abdominal 
aorta. Accessory renal arteries are present in 30% of individuals; they arise commonly 
from the aorta, run parallel to the renal artery, and enter the kidney either at the hilus 
or at one of its poles. 
At or near the hilus the renal artery divides into anterior and posterior 
divisions. Further branching of these divisions gives rise to segmental arteries each of 
which supplies one vascular segment. Five such segments are described. These are 
apical, upper, middle, lower and posterior. The segmental arteries are end arteries, so 
that the vascular segments are independent units. 
VENOUS DRAINAGE 
The venous end of the peritubular capillary plexus gives rise to interlobular 
veins which run along the corresponding arteries. The interlobular veins drain into the 
arcuate veins, which in their turn open into the interlobar veins. These emerge at the 
renal sinus and join to form the renal vein which drains into the inferior vena cava. 
The venous end of the capillary plexus along the vasa recta gives rise to veins 
which drain into the arcuate veins. 
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LYMPHATIC DRAINAGE 
The lymphatics of the kidney drain into the lateral aortic nodes located at the 
level of origin of the renal arteries. 
 
 
NERVE SUPPLY 
The kidney is supplied by the renal plexus, an offshoot of the celiac plexus. It 
contains sympathetic (T10 – L1) fibres which are chiefly vasomotor. The afferent 
nerves of the kidney belong to segments T10 to T12. 
FUNCTIONS OF KIDNEYS 
Kidneys perform vital functions. By excreting urine, kidneys play principal role in 
the maintenance of internal environment. In addition, kidneys perform many other 
functions as described below. 
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1. ROLE OF HOMEOSTASIS 
The primary function of kidneys is homeostasis. It is accomplished by the 
formation of urine. Kidneys are not only the excretory organs, but are also the 
regulatory organs because their major role is in homeostasis. During the formation of 
urine, kidneys regulate various activities in the body, which are concerned with 
homeostasis. 
Excretion of waste products: Removal of wastes help in homeostasis. 
Kidneys excrete the unwanted waste products which are formed during metabolic 
activities. 
a. Urea – end product of amino acid metabolism 
b. Uric acid – end product of nucleic acid metabolism 
c. Creatinine – end product of metabolism in muscles 
d. Bilirubin – end product of hemoglobin degradation 
e. Products of metabolism of other substances. 
Kidneys also excrete harmful foreign chemical substances like: 
a. Toxins 
b. Drugs 
c. Heavy metals 
d. Pesticides etc., 
Maintenance of water balance: Kidneys maintain the water balance in the body 
by conserving water when it is decreased and excreting water when it is excess in 
the body. This is a very important process for homeostasis. 
Maintenance of electrolyte balance: Maintenance of electrolyte balance, 
especially sodium is in relation to water balance. Kidneys retain sodium if the 
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osmolarity of body water decreases and eliminate sodium when osmolarity 
increases. 
 
Maintenance of acid base balance: The pH of the blood and body fluids should 
be maintained within narrow range for healthy living. It is achieved by role of 
kidneys. Body is under constant threat to develop acidosis, because of production 
of lot of acids during metabolic activities. However, it is prevented by kidneys, 
lungs and blood buffers, which eliminate these acids. Among these organs, 
kidneys play major role in preventing acidosis. In fact, kidneys are the only 
organs, which are capable of eliminating certain metabolic acids like sulfuric and 
phosphoric acids. 
2. HEMOPOIETIC FUNCTION 
Kidneys stimulate the production of erythrocytes by secreting erythropoietin. 
Erythropoietin is the important stimulating factor for erythropoiesis. Kidney also 
secretes another factor called thrombopoietin, which stimulates the production of 
thrombocytes. 
3. ENDOCRINE FUNCTION 
Kidneys secrete many hormonal substances in addition to erythropoietin and 
thrombopoietin. The hormones secreted by kidneys are: 
a. Erythropoietin 
b. Thrombopoietin 
c. Renin 
d. 1, 25 – Dihydroxycholecalciferol 
e. Prostaglandins 
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4. REGULATION OF BLOOD PRESSURE 
Kidneys play an important role in the regulation of arterial blood pressure. 
Kidneys regulate arterial blood pressure by two ways: 
1. By regulating the volume of extracellular fluid 
2. Through renin – angiotensin mechanism 
5. REGULATION OF BLOOD CALCIUM LEVEL 
Kidneys play a role in the regulation of blood calcium level by activating 1, 25 
– dihydroxycholecalciferol into vitamin D. Vitamin D is necessary for the 
absorption of calcium from intestine
44
. 
MECHANISM OF URINE FORMATION 
 The process involve in urine formation are, 
1. Glomerular filtration 
2. Tubular reabsorption 
3. Tubular secretion 
GLOMERULAR FILTRATION 
 Glomerular filtrate is protein free plasma. Glomerular filtration is depends 
upon hydrostatic pressure of the afferent arterioles, glomerular capillary pressure and 
colloidal osmotic pressure. The glomerular filter contains all the substance present in 
the plasma except colloids. 
           About 170  litres of  glomerular filtrates enters the renal tubule per day and 
about 168.5 litres of urine reabsorbed in the renal tubule. 
 Normal amount of urine excreted per day is about 1.5 litres. The glomerular 
filtrate is alkaline. It contains water, small quantities of urea, glucose, potassium, 
calcium, bicarbonates and uric acid. 
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TUBULAR REABSORPTION 
 When the glomerular filtrate flows through the tubular portion of nephron, 
both quantitive and qualitative changes occur. Large quantity of water (more than 
99%), electrolytes and other substances are reabsorbed by the tubular epithelial cells. 
The reabsorbed substances move into the interstitial fluid of renal medulla. And, from 
here, the substances move into the blood in peritubular capillaries. 
 Since the substances are taken back into the blood from the glomerular filtrate, 
the entire process is called tubular reabsorption. 
TUBULAR SECRETION 
 In addition to reabsorption from renal tubules, some substances are also 
secreted into the lumen from the peritubular capillaries through the tubular epithelial 
cells. It is known as tubular secretion or tubular excretion. Drug mercurial diuretics, 
ammonium , potassium, hydrogen ion etc. are excreted by tubular secretion. 
 Thus, urine is formed in the nephron by the processes of glomerular filtration, 
selective reabsorption and tubular secretion
45
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URETERS 
The ureters are a pair of narrow, thick-walled muscular tubes which convey 
urine from the kidneys to the urinary bladder.  
They lie deep to the peritoneum, closely applied to the posterior abdominal 
wall in the upper part, and to the lateral pelvic wall in the lower part. 
DIMENSIONS 
Each ureter is about 25 cm (10 in.) long, of which the upper half (5 in.) lies in 
the abdomen, and the lower half (5 in.) in the pelvis. It measures about 3mm in 
diameter, but it is slightly constricted at three places. 
COURSE 
The ureter begins within the renal sinus as a funnel shaped dilatation, called 
the renal pelvis. The pelvis issues from the hilus of the kidney, descends along its 
median margin, or partly behind it. Gradually it narrows till at the lower end of the 
kidney it becomes the ureter proper. 
The ureter passes downwards and slightly medially on the psoas major muscle, 
and enters the pelvis by crossing in front of the termination of the common iliac 
artery. In the lesser or true pelvis the ureter at first runs downwards, and slightly 
backwards and laterally, following the anterior margin of the greater sciatic notch. 
Opposite the ischial spine it turns forwards and medially to reach the base of the 
urinary bladder. The ureter enters the bladder wall obliquely to open into it at the 
lateral angle of its trigone. 
 
CONSTRICTIONS 
The ureter is slightly constricted at three places:  
1) The first at the pelvic ureteric junction about 5.5 cm below the hilum of the 
kidney;  
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2) Second at  brim of the lesser pelvis where the ureter crosses in front of the 
common iliac artery; 
3)Third is just before it enters the bladder .The renal stones tend to get arrested 
at these places. 
BLOOD SUPPLY 
Upper part receives branches from renal artery, gonadal or colic vessels, 
middle part receives branches from aorta, the gonadal or iliac vessels, and pelvic part 
is supplied by branches from the vesical, middle rectal or uterine vessels. 
NERVE SUPPLY 
The ureter is supplied by sympathetic from T10 – L1 segments and 
parasympathetic from S2 – S4 nerves. They reach the ureter though the renal, aortic 
and hypogastric plexuses. All the nerves appear to be sensory in function
46
. 
URINARY BLADDER 
The urinary bladder is a muscular reservoir of urine, which lies in the anterior 
part of the pelvic cavity. The detrusor muscle of urinary bladder is arranged in whorls 
and spirals and is adapted for mass contraction rather than peristalsis. 
SIZE, SHAPE AND POSITION 
The bladder varies in its size, shape and position according to the amount of 
urine it contains. When empty it lies entirely within the pelvis; but as it fills it expands 
and extends upwards into the abdominal cavity, reaching up to the umbilicus or even 
higher. 
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EXTERNAL FEATURES 
An empty bladder is tetrahedral in shape and has: 
 An apex, directed forwards; 
 A base or fundus, directed backwards; 
 A  neck, which is the lowest and most fixed part of the bladder;  
 Three surfaces, superior and right and left inferolateral; and  
 Four borders, two lateral, one anterior and one posterior. 
A full bladder is ovoid in shape and has: 
 An apex, directed upwards towards the umbilicus; 
 a neck, directed downwards, and 
 two surfaces, anterior and posterior. 
INTERNAL SPHINCTER OF THE BLADDER 
The bladder wall is made up of longitudinal and circular layers of smooth 
muscles and they are called detrusor muscle. In the trigone in addition to detrusor 
muscle, there is trigonal muscle of bell. There is no definite circular muscle fibre at 
the neck of the bladder stop at the level of neck. Longitudinal fibres from the posterior 
wall diverge to pass around the urethra on both sides. 
CAPACITY OF THE BLADDER 
The mean capacity of the bladder in an adult male is 220 ml, varying from 120 
to 320 ml. filling beyond 220 ml causes a desire to micturate, and the bladder is 
usually emptied when filled to about 250 – 300 ml. filling upto 500 ml may be 
tolerated, but beyond this it becomes painful. Referred pain is felt in the lower part of 
the anterior abdominal wall, perineum and penis (T11 to L2; S2 – S4). 
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BLOOD SUPPLY 
Superior vesicle arteries and inferior vesicle arteries supplies the bladder. In 
addition branches from obturator and inferior gluteal artery are supplied to the 
bladder. 
 
NERVE SUPPLY 
Sympathetic fibers arise from T11 – L2 segment. Parasympathetic fibres branches 
from S2 – S4. Somatic pudental nerve supplies the sphincter urethrae which is 
voluntary. 
URETHRA 
Urethra is a tubular passage extending from the neck of the bladder to the external 
urethral orifice. 
 The male urethra extends from the internal urethral orifice at the neck of 
urinary bladder to the external urethral orifice at the tip of the penis. It is about 20 
cm long in flaccid state of the penis; the long axis of urethra shows 2 curvatures 
and is therefore S shaped. In the erect state it becomes J shaped. 
It is divided into 3 parts 
1) Prostatic part                     : Passes through prostate (3 cm long) 
2) Membraneous part            : Surrounded by sphincter (2 cm long) 
3) Spongy part (Penile part)  : Passes through the bulb and carpus 
                                               spongiosum  (15 cm long)
47
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SPHINCTER OF THE URETHRA 
 There are 2 sphincters, in relation with urethra internal and external. The 
internal sphincter made up of smooth muscle fibre and situated at the neck of the 
bladder is supplied by sympathetic nerves from lower thoracic segments and upper 
lumbar segments. 
 The external sphincter made of light striated muscle fibre surrounds the 
membraneous part of urethra; it is supplied by prineal branch of the pudental nerve 
(S2 to S4). 
BLOOD SUPPLY 
 Branches of internal pudental artery supplies urethra
48
. 
THE FEMALE URETHRA 
The female urethra is only 4 cm long and 6 mm in diameter. Developmentally, 
it corresponds to the upper part of the prostatic urethra of the male. 
 It begins at the internal urethral orifices roughly 5 cm behind the middle of the 
pubic symphysis. It runs downwards and forwards embedded in the anterior wall of 
the vagina, traverse the urogenital diaphragm and ends at the lateral urethral orifices 
in the vestibule. 
 The mucosa of the urethra is much folded and contains numerous mucous 
glands and lacunae which open into the urethra. The collections of mucous glands one 
on each side of the upper part of the urethra is called the paraurethral glands of skene. 
 The female urethra is dilatable
48
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REVIEW OF LITERATURE  
 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 48 
 
RENAL CALCULI (UROLITHIASIS) 
 
 
  It refers to calculus formation at any level in the urinary tract but most 
arise in the kidney.calculi are common in the renal pelvis, calyces and collecting ducts 
of people in industrialized countries, and is the third most common disorder of the 
urinary tract
49
. 
Urolithiasis is a frequent clinical problem, affecting 5 to 10% of Americans in their 
lifetime. Males are affected more often than females and the peak age at onset is 
between20 and 30 years. Familial hereditary predisposition to stone formation has 
long been known. Many of the inborn errors of metabolism, such as gout   cystinuria, 
and primaryhyperoxaluria, provide good examples of hereditary disease characterized 
by excessiveproduction and excretion of stone -forming substances
50
. 
   In underdeveloped countries nephrolithiasis is rare. In Britain and USA the 
incidence of renal calculi has become at least 10 times higher in the past 90 years. 
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This increase may be related to changes in diet e.g. increase in protein diet. Current 
annual incidence in Britain and the USA ranges from 6.87 to 20.8 per 10,000 of the 
population. A familial tendency toward stone formation has long been recognized. 
 If stones grow to sufficient size (usually at least 3 millimeters (0.12 in)) they 
can cause obstruction of the ureter. Ureteral obstruction causes postrenal azotemia and 
hydronephrosis (distention and dilation of the renal pelvis and calyces), as well as 
spasm of the ureter. This leads to pain, most commonly felt in the flank (the area 
between the ribs and hip), lower abdomen, and groin (a condition called renal colic). 
Renal colic can be associated with nausea, vomiting, fever, blood in the urine, pus in 
the urine, and painful urination. Renal colic typically comes in waves lasting 20 to 60 
minutes, beginning in the flank or lower back and often radiating to the groin or 
genitals. The diagnosis of kidney stones is made on the basis of information obtained 
from the history, physical examination, urinalysis and radiographic studies. 
Ultrasound examination and blood tests may also aid in the diagnosis.
51
 
Renal calculi are formed when the urine is supersaturated with salt and 
minerals such as calcium oxalate, struvite (ammonium magnesium phosphate), uric 
acid and cystine.60-80% of stones contain calcium
52
. They vary considerably in size 
from small 'gravel-like' stones, to large staghorn calculi. The calculi may stay in the 
position in which they are formed, or migrate down the urinary tract, producing 
symptoms along the way. Studies suggest that the initial factor involved in the 
formation of a stone may be the presence of nanobacteria that form a calcium 
phosphate shell
53,54.
. 
The other factor that leads to stone production is the formation of Randall's 
plaques. Calcium oxalate precipitates form in the basement membrane of the thin 
loops of Henle; these eventually accumulate in the subepithelial space of the renal 
papillae, leading to a Randall's plaque and eventually a calculus.
55
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Pathophysiology 
 
 
Urinary calculi are consist of aggregates of crystals, usually containing 
calcium or phosphate in combination with small amounts of proteins and 
glycoproteins. In developed countries, however, most calculi occur in healthy young 
men, in whom investigations reveal no clear predisposing cause. Renal stones vary 
greatly in size. There may be particles like sand anywhere in the urinary tract, or large 
round stones in the bladder.  
 In developing countries bladder stones are common, particularly  in  children. 
In developed countries, the incidence of childhood bladder stones is low; renal stones 
in adults are more common. Staghorn calculi fill the whole renal pelvis and branch 
into the calyces; they are usually associated with infection and composed largely of 
struvite.  
Deposits of calcium may be present throughout the renal parenchyma, giving 
rise to fine calcification within it (nephrocalcinosis), especially in patients with renal 
tubular acidosis, hyperparathyroidism, vitamin D intoxication and healed renal 
tuberculosis. Cortical nephrocalcinosis  may occur in areas of cortical necrosis, 
typically after AKI in pregnancy or other severe AKI. 
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PREVALENCE 
Renal stone disease is common , affecting individuals of all countries and 
ethnic groups. In the UK, the prevalence is about 1.2%, with a lifetime risk of 
developing a renal stone at age 60-70% of about 7% in men. In some regions the risk 
is higher, most notably in countries like Saudi Arabia, where the lifetime risk of 
developing a renal stone in men aged 60-70 is just over 20%.
56
 
EPIDEMIOLOGY 
 Renal stones are common, being present at some time in one in ten of the 
population, although a significant proportion will remain asymptomatic. 
 The annual incidence is about 1-2 cases of acute renal colic per 1,000 people 
and the average lifetime risk around 5-10%. 
 Men are more commonly affected than women, with a male to female ratio of 
3:1. The difference between the sexes is gradually being eroded. This is 
thought to be due to lifestyle-associated factors, such as obesity and a Western 
diet. 
 The peak age for developing stones is between 30 and 50 and recurrence is 
common
52
. 
ETIOLOGY AND PATHOGENESIS 
 The crystals in the stone in the kidney are commonly mixed, although there is 
usually a preponderance of crystals from one particular solute. 70-75% of renal stones 
are composed almost entirely of calcium oxalate, mixed with calcium phosphate. 15% 
of calculi consist predominantly of magnesium ammonium phosphate (struvite). Uric 
acid stones and cysteine stones together account for about 10% of calculi. Very rarely 
stones are made up of almost pure xanthine, silica or some chemical foreign to the 
body. 
Uric acid crystals are commoner in some parts of the Middle East, India and 
North Africa than in Europe and the USA. 
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The formation of stones within the kidney is not a specific disease; it is potential 
complication of many different disorders. The cause is obscure. The most important is 
almost certainly an increased urine concentration of the some constiuents
57
. 
TYPES OF RENAL CALCULI 
 
  There are 4 main tyoes of renal calculi- calcium containing, mixed(struvite), uric 
acid and cysteine stones, a few rare types. 
1) CALCIUM STONES 
 
        Calcium stones are the most common comprising about 75% of all urinary 
calculi. They may be pure stones of calcium oxalate (50%), or calcium phosphate 
(5%), or mixture of calcium oxalate and calcium phosphate (45%). 
Etiology 
Etiology  of calcium stones are variable. 
About 50% of patients with calcium stones have idiopathic hypercalciuria without 
hypercalcaemia.  
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Approximately 10 % cases are associated with hypercalcaemia and 
hypercalciuria, the most commonly due to hyperparathyroidism, or a defect in the 
bowel (i.e. absorptive hypercalciuria), or in the kidney (i.e. renal hypercalciuria). 
About 15% of patients with calcium stones have hyperuricosuria with a 
normal blood uric acid level and without any abnormality of calcium metabolism. 
In about 25% of patients with clcium stones, the cause is known as there is no 
abnormality in urinary excretion of calcium, uric acid or oxalate and is referred to as 
idiopathic calcium stone disease. 
Pathogenesis  
The mechanism of calcium stone formation is explained on the basis of 
imbalance between the degree of supersaturation of the ions forming the stone and the 
concentration of inhibitors in the urine. Most likely site where the crystals of calcium 
oxalate and / or calcium phosphate are precipitated is the tubular lining or around 
some fragment of debris  in the tubule acting as nidus of the stone. The predisposing 
factors contributing to formation of calcium stones are alkaline pH, decreased urinary 
volume and increased excretion of oxalate and uric acid 
Morphology  
Calcium stones are usually small (less than a centimeter), ovaid, hard, with 
granular rough surface. They are dark brown due to old blood pigment deposited in 
them as a result of repeated trauma caused to the urinary tract by these sharp – edged 
stones. 
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2.MIXED STONES 
 
About 15% of urinary calculi are made of magnesium-ammonium-calcium 
phosphate, often called struvite; hence mixed stones are also called as struvite stones 
or triple phosphate stones. 
Etiology  
Struvite stones are formed as a result of infection of the urinary tract with 
urea- splitting organisms that produce urease such as by specious of Proteus, and 
occasionally klebsiella, pseudomonas, and  Enterobacter. these are, therefore, also 
known as infection – induced stones. However, E.coli does not form urease. 
Morphology  
Struvite stones are yellow- white or grey. They tend to be soft and irregular in 
shape. Staghorn stone which is large, solitary stone that takes the shape of the renal 
pelvis where it is often formed is an example of struvite stone
57
 
3).URIC ACID STONES  
 
Approximately 6% of urinary calculi are made of uric acid. Uric acid calculi 
are radiolucentunlike radio- opaque calcium stones. 
Etiology 
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Uric acid stones are frequently formed in cases with hyperuricaemia and 
hyperuricosuria such as due to primary gout or secondary gout due to 
myeloproliferative disorders (e.g. in  leukaemias), especially those on chemotherapy, 
and administration of uricosuric drugs (e.g. salicylates, probenacid). Other factors 
contributing to their formation are acidic urinary pH (below 6) and low urine volume. 
Pathogenesis 
The solubility of uric acid at pH of 7 is 200 mg/ dl while at pH of 5 is            
15 mg /dl. Thus as the urine becomes more acidic, the solubility of uric acid in urine 
decreases and precipitation of uric acid crystals increases favoring the formation of 
uric acid stones. Hyperuricosuria is the most important factor in the production of uric 
acid stones, while hyperuricaemia is found in about half the cases. 
Morphology 
Uric acid stones are smooth, yellowish- brown, hard and often multiple. On 
cut section, they show laminated structure. 
4).CYSTINE STONE 
Cysteine stones comprise less than 2% of urinary calculi. 
 Etiology 
Cysteine are associated with cystinuria due to a genitically- determined defect 
in the transport of cysteine and other amino acids across the cell membrane of the 
renal tubules and the small intestinal mucosa. 
Pathogenesis 
The resultant excessive excretion of cysteine which is least soluble of the 
naturally- occurring amino acids leads to formation of crystals and eventually cysteine 
calculi. 
  
REVIEW OF LITERATURE  
 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 56 
 
Morphology 
cysteine  stones are small, rounded, smooth and multiple. They are yellowish and 
waxy. 
5.OTHER CALCULI 
Less than 2% of urinary calculi consist of other rare types such as due to inherited 
abnormality of enzyme metabolism e.g. hereditary xanthinuria developing xanthine 
stones
58
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 CLINICAL COURSE 
 Stones are of importance when they obstruct urinary flow or produce 
ulceration and bleeding. They may be present without producing any symptoms or 
significant renal damage. In general, smaller stones are most hazardous, as they may 
pass into the ureters, producing pain referred to as colic (one of the most intense 
forms of pain) as well as ureteral obstruction. Larger stones cannot enter the ureters 
and are more likely to remain silent within the renal pelvis. Commonly, these larger 
stones first manifest themselves by hematuria. Stones also predispose to 
superimposed infection, both by their obstructive nature and by the trauma they 
produce
59
.  
MORPHOLOGY OF KIDNEY 
  In 80% of patients, stones are unilateral. Common sites are renal pelvis, 
calyces and the bladder. Calcium oxalate crystals are mostly unilateral and solitary. 
They are usually either yellow-brown or dark from altered blood, and hard. 
Predominantly oxalate calculi may be nodular with smaller blunt spikes; mixed 
oxalate and phosphate stones may be fairly smooth. If small they are triangular in 
section. The nodular form may be called mulberry type in Britain or the jackstone 
type in the USA. Occasionally progressive accretion of salts leads to the development 
of branching structures known as staghorn  calculi, which create a cast of the renal 
pelvic and calyceal system. These massive stones are usually composed of 
magnesium ammonium phosphates
57
.   
REVIEW OF LITERATURE  
 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 57 
 
CLINICAL FEATURES    
 The clinical presentation is highly variable. Most patients with renal stone 
disease are asymptomatic, whereas others present with pain, hematuria, UTI, or 
urinary tract infection.  
 A common presentation is with acute loin pain radiating to the anterior 
abdominal wall, together with hematuria; a symptom complex termed renal or ureteric 
calculi. This most commonly caused by a calculus but the same symptoms can occur 
in association with a sloughed renal papilla, tumour or blood clot. 
 The patient is suddenly aware of pain in the loin, which radiates round the 
flank to the groin and often into the testis or labium, in the sensory distribution of the 
first lumbar nerve. The pain steadily increase in intensity to reach a peak in a few 
minutes.  
 The patient is restless and generally tries unsuccessfully to obtain relief by 
changing position or packing the room. There is pallor, sweating, and often vomiting. 
Frequency, dysuria, and hematuria may occur. The intense pain usually subsides 
within 2 hours but may continue unabated for hours or days
56
.  
PRESENTATION   
 Many stones are asymptomatic and discovered during investigations for other 
conditions. 
 The classical features of renal colic (or ureteric colic) are sudden severe pain. 
It is usually caused by stones in the kidney, renal pelvis or ureter, causing 
dilatation, stretching and spasm of the ureter. In most cases no cause is found: 
 Pain starts in the loin about the level of the costovertebral angle (but 
sometimes lower) and moves to the groin, with tenderness of the loin or renal 
angle, sometimes with haematuria. 
 If the stone is high and distends the renal capsule then pain will be in the flank 
but as it moves down pain will move anteriorly and down towards the groin. 
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 A stone that is moving is often more painful than a stone that is static. 
 The pain radiates down to the testis, scrotum, labia or anterior thigh. 
 Whereas the pain of biliary or intestinal colic is intermittent, the pain of renal 
colic is more constant but there are often periods of relief or just a dull ache 
before it returns. The pain may change as the stone moves. The patient is often 
able to point to the place of maximal pain and this has a good correlation with 
the current site of the stone. 
Other symptoms which may be present include:  
 Rigors and fever. 
 Dysuria. 
 Haematuria. 
 Urinary retention. 
 Nausea and vomiting
52
. 
PREDISPOSING FACTORS FOR KIDNEY STONES 
Environmental and dietary: 
 Low urine volumes, high ambient temperatures, low fluid 
intake 
 Diet: high protein intake, high sodium, low calcium 
 High sodium excretion 
 High urate excretion 
 High oxalate excretion 
 Low citrate excretion  
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Acquired causes: 
 Hypercalcemia of any cause 
 Ileal disease or resection (leads to increased oxalate absorption and urinary 
excretion) 
 Renal tubular acidosis type I 
Congenital and inherited causes: 
 Familial hypercalciuria 
 Renal tubular acidosis type I (distal) 
 Medullary sponge kidney 
 Cystinuria 
 Primary hyperoxaluria 
The majority of stones pass spontaneously within 48 hours. However, some 
stones may not. There are several factors which influence the ability to pass a stone. 
These include the size of the person, prior stone passage, prostate enlargement, 
pregnancy, and the size of the stone. A 4 mm stone has an 80% chance of passage 
while a 5 mm stone has a 20% chance. If a stone does not pass, certain procedures 
(usually by a urology specialist doctor) may be needed
60
.  
RISK FACTORS 
Several risk factors are recognised to increase the potential of a susceptible individual 
to develop stones. These include: 
 Anatomical anomalies in the kidneys and/or urinary tract - eg, horseshoe 
kidney, ureteral stricture. 
 Family history of renal stones. 
 Hypertension. 
 Gout. 
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 Hyperparathyroidism. 
 Immobilisation. 
 Relative dehydration. 
 Metabolic disorders which increase excretion of solutes - eg, chronic 
metabolic acidosis, hypercalciuria, hyperuricosuria. 
 Deficiency of citrate in the urine. 
 Cystinuria (an autosomal-recessive aminoaciduria). 
 Drugs - eg, diuretics such as triamterene and calcium/vitamin D 
supplements. 
 More common occurrence in hot climates. 
 Increased risk of stones in higher socio-economic groups. 
 Contamination - as demonstrated by a spate of melamine-contaminated 
infant milk formula
61
. 
EXAMINATION 
 The patient with colic of any sort writhes around in agony. This is in contrast 
to the patient with peritoneal irritation who lies still. 
 The patient is apyrexial in uncomplicated renal colic (pyrexia suggests 
infection and the body temperature is usually very high with pyelonephritis). 
 Examination of the abdomen can sometimes reveal tenderness over the 
affected loin. Bowel sounds may be reduced. This is common with any severe 
pain. 
 There may be severe pain in the testis but the testis should not be tender. 
 Blood pressure may be low. 
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 Full and thorough abdominal examination is essential to check for other 
possible diagnoses - eg, acute appendicitis, ectopic pregnancy, aortic 
aneurysm
52.
 
DIFFERENTIAL DIAGNOSIS  
This depends upon the position of the pain and the presence or absence of pyrexia 
and includes: 
 Biliary colic. 
 Pyelonephritis: very high temperature. Pain is unlikely to radiate to the groin. 
 Acute pancreatitis 
 Acute appendicitis 
 Perforated peptic ulcer. 
 Epididymo – orchitis or torsion of the testis: very tender testis. 
 Sinister causes of back pain: usually tender over vertebrae. 
 Dissection of an aortic aneurysm: the patient who presents with features of 
renal colic for the first time over the age of 60. This may be dissection of 
aortic aneurysm leading to ruptured aortic aneurysm. 
 Drug addiction: there are reports of people with fictitious stories of renal colic, 
designed to obtain an injection of pethidine. These patients tend to be abusive 
when offered anything other than pethidine
62.
 
INVESTIGATIONS 
Basic analysis should include: 
 Blood for FBC, CRP, renal function, electrolytes, calcium, phosphate and 
urate, creatinine. 
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 Midstream specimen of urine for microscopy (pyuria suggests infection), 
culture and sensitivities. 
 Prothrombin time and international normalised ratio if intervention is planned. 
 Stick testing of urine for red cells (suggestive of urolithiasis), white cells and 
nitrites (both suggestive of infection) and pH (pH above 7 suggests urea-
splitting organisms such as Proteus spp. whilst a pH below 5 suggests uric 
acid stones). 
  Intravenous pyelogram (IVP)
63
. 
 Computed tomography (CT) 
  Ultrasound scanning may be helpful to differentiate radio-opaque from 
radiolucent stones and in detecting evidence of obstruction. 
 Plain X-rays of the kidney, ureter and bladder (KUB) are useful in watching 
the passage of radio-opaque stones (around 75% of stones are of calcium and 
so will be radio-opaque). 
 The European Association of Urology's guidelines on urolithiasis recommend 
stone analysis for: 
 All first-time stone formers. 
 All patients with recurrent stones who are on pharmacological preventing 
therapy. 
 Patients who have had early recurrence after complete stone clearance. 
 Late recurrence after a long stone-free period (stone composition may 
change)
64
. 
  
REVIEW OF LITERATURE  
 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 63 
 
COMPLICATIONS  
The complications of calcium oxalate and hydroxyapatite renal calculi are 
acute and chronic pyelonephritis, hydronephrosis and obstructive nephropathy.  
 The stone fragments may obstruct the ureter. This occurs in 5-15% of cases. 
8% of patients develop hypertension or exacerbation of pre- existing hypertension 
within 1 year. thirdly there is a risk of renal damage.  
  HYDRONEPHROSIS 
In bilateral complete obstruction, patient present with anuria.  When the 
obstruction is below the bladder the dominant symptoms are bladder distention. 
Unilateral hydronephrosis may remain completely silent for long periods of time. 
Enlargement of kidney is made out on physical examination. Sometimes the 
obstructing cause e.g. calculi can produce symptoms. 
Early removal of the cause of obstruction can return the full function of the 
kidney. In long standing cases the changes become irreversible. 
Two metabolic disorders need to be mentioned here which are associated with 
precipitation of the crystalline material causing obstruction to urine flow. 
1.HYPERURICAEMIA 
 Uric acid stones are formed In 22% of patients with gout. The urate crystals 
get deposited in distal collecting tubules. Collecting ducts as well in the interstitium, 
forming gouty tophus. Uric acidcrystal deposition takes place also following 
chemotherapy to the patients of leukemia and lymphoma. this is due to the breaking 
down of nucleic acid.  
2.HYPERCALCAEMIA 
Hyperparathyroidism, end stage kidney disease, vit. D intoxication, excessive 
calcium intake, osteolytic disease of bones, milk- alkali syndrome are some of the 
conditions giving rise to hypercalcaemia. This induces deposition of calcium in renal 
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tubules called nephrocalcinosis.  Sometimes, the deposition can also form renal 
stones
57
. 
Complete blockage of the urinary flow from a kidney decreases glomerular 
filtration rate (GFR) and, if it persists for more than 48 hours, may cause irreversible 
renal damage. 
If ureteric stones cause symptoms after four weeks, there is a 20% risk of 
complications, including deterioration of renal function, sepsis and ureteric stricture. 
Infection can be life-threatening. 
Persisting obstruction predisposes to pyelonephritis
64
. 
PROGNOSIS 
The prognosis will depend upon the underlying condition causing the renal stones. 
Calcium oxalate and hydroxyapatite stones per se rarely lead to renal failure. If at the 
time of diagnosis there is renal damage due to the calculi then this may cause renal 
dysfunction and hypertension. The main problem is recurrence unless the causative 
condition can be treated ; the recurrence rate is high, approaching 70% by 10 years 
after spontaneous passage or surgical removal of a calculus
65
. 
 Most symptomatic renal stones are small (less than 5 mm in diameter) and 
pass spontaneously. 
 Stones less than 5 mm in diameter pass spontaneously in up to 80% of people. 
 Stones between 5 mm and 10 mm in diameter pass spontaneously in about 
50% of people. 
 Stones larger than 1 cm in diameter usually require intervention (urgent 
intervention is required if complete obstruction or infection is present). 
 Two thirds of stones that pass spontaneously will do so within four weeks of 
onset of symptoms. 
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 A stone that has not passed within 1-2 months is unlikely to pass 
spontaneously. 
 The following features predispose to recurrent stone formation: 
 First attack before 25 years of age. 
 Single functioning kidney. 
 A disease that predisposes to stone formation. 
 Abnormalities of the renal tract. 
PREVENTION 
Recurrence of renal stones is common and therefore patients who have had a renal 
stone should be advised to adapt and adopt several lifestyle measures which will help 
to prevent or delay recurrence: 
 Increase fluid intake to maintain urine output at 2-3 litres per day. 
 Reduce salt intake. 
 Reduce the amount of meat and animal protein eaten. 
 Reduce oxalate intake (foods rich in oxalate include chocolate, rhubarb, nuts) 
and urate-rich foods (eg, certain fish). 
 Drink regular cranberry juice: increases citrate excretion and reduces oxalate 
and phosphate excretion. 
CALCIUM 
 Maintain good calcium intake(calcium forms an insoluble salt with dietary 
oxalate, lowering oxalate absorption and excretion). 
 Avoid calcium supplements separate from meals (increase calcium excretion 
without reducing oxalate excretion). 
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OXALATE 
Depending on the composition of the stone, medication to prevent further 
stoneformation is sometimes given - eg, thiazide diuretics (for calcium 
stones),allopurinol (for uric acid stones) and calcium citrate (for oxalate stones). 
DIET RESTRICTION; 
Uric acid and urate calculus 
 Red Meat 
 Beef 
 Chicken 
 Fish 
 Peanuts 
 Liver which are rich in purine 
Cystine calculi 
 Sulphur containing proteins such as meat ,fish and eggs 
Calcium oxalate stones 
A high fluid intake is most important as it will increase urinary volume and decrease 
the concentration of calcium oxalate. 
 Tea ,nuts and some green leafy vegetables are high in oxalates 
 Restriction of salt and fat intake 
 Dairy products 
 Foods high in oxalates are –Tomato, strawberries, plumbs, spinach etc 
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FOOD AND DRINKS CONTAINING CALCIUM OXALATE; 
A diet low in oxalates are more reasonable than a calcium restricted diet. 
 Apples                                                         Figs 
 Asparagus                                                  Grapes     
 Beer                                                           Ice cream 
 Beets                                                          Milk 
 Berries                                                       Oranges 
 Black pepper                                             Peanut butter 
 Cheese                                                      Pine apples  
 Chocolate                                                 Spinach 
 Cocoa                                                       Tea 
 Coffee                                                      Turnips 
 Cola drinks                                               Vitamin C 
 
These foods can be eaten in very limited amounts under the advice of the 
doctor. 
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TRIAL MEDICINE 
fšyil¥ò Nuz« 
 
“Ódh¡fhu« bghçfhuŠ  nr®¤J¥  òrt®¡ fhuª  
jhd¤ bjhL¤J«  bghoah¡»¤  jåahÍUé  gd§fÂU«  
ghd§fjç¤  j©Llnd ¥çthŒ¢ R£L¢ rçrkdhŒ¤ 
njå‰FiH¤J  éG§»lnt¿ bj¿¡FŠ  rijfšyil¥ghnk”  
               Mjhu« - mf¤Âa® MÍŸntj« 1200, g¡f v© 125. 
Ingredients  
 Purified Padigaram 
 Purified Venkaram 
 Purified Induppu 
 Purified Savukkaram 
 Nayuruvi 
 Panaingathir 
 VaazhaiMattai 
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ACTIONS OF TRIAL MEDICINE 
S.No. Drugs Botanical Name Actions 
1. Purified Padigaram Alumen Alum Astringent 
Antiseptic 
Antispasmodic 
Styptic  
2. Purified Venkaram Borax (Sodium Biborate)  Diuratic 
Lithontriptic 
Refrigerant  
3. Purified Induppu Sodium Chloride (Rock 
Salt)  
Carminative  
Diuretic  
Stomachic  
4. Purified Savukkaram Sodium Carbonate Antipitha 
5. Nayuruvi Achyranthesaspera Astringent  
Diuretic
66 
Anti Periodic 
6. Panaingathir Borassusflabellifermis Astringent  
Diuretic
67
 
7. VazhaiMattai Mucasapientum Refrigerant  
Diuretic
68 
Antipitha 
 
1. gofhu« - Alumen Alum  
bghJ¡ Fz« 
ÓdbkD« fhukJÓ¿tU« gšyuiz 
Mid¡fhšf©nzhŒmåynkhL - khãy¤Âš 
J‹kh§»r« thÍnjhyhjcŸsHiy 
F‹käitngh¡Fbkd¡ TW69 
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2. bt§fhu«  - Sodium Biborate 
bghJ¡ Fz«  
 “bt§fhu« r®¥gél« #y« Ú®mil¥ò 
 k§fhj »uhâu¤jkh« _y« - gŠfŠbrŒ 
 thÍÎl‹ fšyil¥ò t‹»UämZlF‹k« 
 XÍ« go òçÍ« XJ” 70 
 
3. ÏªJ¥ò -Sodium Chloride Impura 
bghJ¡ Fz«  
 “m£lF‹kkªj« mÁ®¡fuŠN® ÓjÃ¤jª 
 J£lita« eho¥¥ò© nlhl§fŸ - bf£lky¡ 
 R£Léléªija¡ fhäanehŒt‹fu¥gh‹ 
 é£LéléªJ¥igéŸ” 71  
 
4.  rÎ¡fhu«    - Sodium Carbonate 
bghJ¡ Fz«  
 “fu¥ghid¢ Ój¤ijf©o¡F« ngÂ 
 cu¥gh¡F« thÍité£nlh£L« - jiu¡FŸ 
 tHiyvd¥ng® tÁ¤jrÎ¡fhu« 
 mHiyF‹k« ngh¡F« m¿”72 
 
5. ehÍUé–Achyaranthesaspera 
bghJ¡ Fz«  
 “XjKWnrhigÍa®gh©Lit¥ngh¡Fª 
 ÔjYfhkhiynehŒ Ô®¡Fäd® - NjfÚ® 
 bghŒ¥òWfhy¤jid¥ bgh§Fé¡F§ fhukhL 
 if¥òWbrª ehÍUé fh©”73 
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6. gd§fÂ® - Borassusflabellifer 
bghJ¡ Fz«  
 “gidæYWótJjh‹ g§fKwh¡ F‹k 
 éidaf‰W« Ú®f£il Û£F« - Kidahd 
 g‹ndhŒxê¡F« gHŠRu¤ij¥ ngh¡»éL« 
 ä‹ndÏjidés«ò” 74 
 
7. thiH–Musa sapientum 
bghJ¡ Fz«  
 “bjhª»DW ä‹DŠRfnghfKk©Q« 
 m¡»åkªjkygybkhL - Â¡»Lfhš 
 ghiHæiy¥òkW« g‹DÃ¤jKŠrkdh« 
 thiHæiy¡ FzUthŒ” 75 
 
STANDARD OPERATIVE PROCEDURE:  
 Take equal amount of purified Padigaram, Venkaram, Induppu & Savukkaram 
make it into fine powder. Take respective ashes of Nayuruvi, Panangathir 
&VaazhaiMattai and mix it.Now take both the powder proportionally equal in amount 
and mix well and store in air tight container.  
DOSAGE : 
 1gm bd after food  
ADJUVANT  
 Honey 
DURATION  
 1 mandalam (48 days) 
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INGREDIENTS OF THE TRIAL MEDICINE 
 
 
               PADIGARAM                                                          VENKARAM 
 
INDUPPU                                             SAVUKKARAM 
 
NAYURUVI                                                     VAAZHAI MATTAI 
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                   PANANGATHIR 
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MATERIALS AND METHODS 
PROTOCOL 
Study Design 
 An open pilot study on Vatha kalladaippu (Urolithiasis) was carried out in the post 
graduate department of maruthuvam in Govt.Siddha Medical College attached to Arignar 
Anna Hospital of Indian Medicine, Chennai – 106 during the period of 2016 – 2018. 
 The study was approved by Instititional Ethics Committee (IEC) and the approval 
number is GSMC-CH-ME-5/001/2016. It was registered in Clinical Trials Registry – India 
(CTRI) and the register number is CTRI/2018/03/012767. 
Sample size 
 The study is conducted in 40 selected Vatha Kalladaippu patients of both genders 
between age groups of 18 to 60 years. 
Selection Criteria 
 The patients having following parameters are selected for the study. 
 Pain in the flank  
 Burning Micturition 
 Oliguria 
 Dysuria  
 Nausea  
 Vomiting  
 Fever  
 History of Urolithiasis (with USG-Whole Abdomen reports)  
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Exclusion Criteria 
 Age group less than 18 
 Stag horn calculus 
 Pyonephrosis 
 Calculi associated with elevated serum creatinine level 
 Calculi in pregnancy 
Proforma 
 The case sheet proforma for Vatha kalladaippu was prepared based on Siddha 
diagnostic methodology with necessary modern techniques. 
History taking 
 For better treatments and results a detailed clinical history was taken regarding  
present illness, past illness, family history, menstrual history, occupational history, socio 
economic status, residential area, etc., 
Investigation 
 All patients were screened by the following investigations. This was carried out 
regularly before and after treatment. 
 Blood for biochemical examination 
The blood was tested for sugar, urea, serum creatinine to know the renal 
function and its excretion. 
 Urine Examination 
         Albumin, Sugar, Deposits. 
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Ultra sonogram 
Ultra sonogram of complete abdomen including KUB was done in cases to know 
the location, size and number of calculi. 
Drug and dose schedule 
 Kalladaippu Chooranam – 1 gm, bd after food with honey for 48 days.  
 
 
 
RESULT 
AND  
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RESULTS AND OBSERVATION 
40 cases having Vatha Kalladaippu were selected and treated in OPD of PG 
Maruthuvam department attached to AAGHIM, Chennai – 106 during the year 2016 – 
2018. The resut and observation during that clinical study are as follows. 
 Gender distribution 
 Age distribution 
 Occupation 
 Socio- economic status 
 Dietary habits 
  Seasonal occurence 
 Distribution of thinai 
 Distribution of mukkutram – vatham 
 Distribution of mukkutram – pitham  
 Distribution of mukkutram – kabham 
 Ezhu udal thathukkal 
 En vagai thervugal 
 Naadi 
 Neikuri 
 Clinical features 
 Clinical prognosis 
 Distribution of calculi based on location 
 Grading of results. 
RESULTS AND OBSERVATION  
 
Kalladaippu Chooranam for VathaKalladaippu Page 78 
 
1. GENDER DISTRIBUTION 
S.No GENDER NUMBER OF CASES PERCENTAGE (%) 
1 Male 24 60% 
2 Female 16 40% 
 
 
INFERENCE 
 About 60% were males and 40% were femalesAccording to literature males 
are more prone to renal calculi. 
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2. AGE DISTRIBUTION 
S.No AGE IN YEARS 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 18 – 20 yrs 0 0 % 
2 21 - 30 yrs 4 10% 
3 31 – 40 yrs 14 35% 
4 41 - 50 yrs 13 32.5% 
5 51 - 60 yrs 9 22.5% 
 
 
INFERENCE 
 Majority of the case that is 35% were in the age group between31-40 yrs, 
32.5% were in the age group between 41-50 yrs, 22.5% were in the age group 
between 51-60 yrs, 10% were in the age group between 21-30 yrs. In this study the 
maximum of the disease were in the age group between 31-40 yrs due to tragedy of 
life, tension and anxiety. 
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3. OCCUPATION 
S.No OCCUPATION 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Office worker 13 32.5% 
2 House Wife 11 27.5% 
3 Business 5 12.5% 
4 Student 1 2.5% 
5 Others 10 25% 
 
 
 
INFERENCE 
 0ut of 40 patients (100%), 32.5% were office worker, 27.5% were house wives 
12.5% were business, 2.5% were student, and 25% were others. 
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4. SOCIO – ECONOMIC STATUS 
S.No 
SOCIO – ECONOMIC 
STATUS 
NUMBER 
OF CASES 
PERCENTAGE (%) 
1 Low Income  
( below 2,00,000 per annum) 
22 55% 
2 Moderate Income  
(200,000 – 5,00,000 per 
annum) 
13 32.5% 
3 High Income  
( Above 5,00,000 per annum) 
5 12.5% 
 
 
INFERENCE: 
 Among 40 cases 55% comes under low economic status, 32.5% of them under 
moderate status and12.5% of them under high income status. 
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5. DIETARY HABITS 
S.No DIET 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vegetarian 10 25% 
2 Mixed diet 30 75% 
 
 
 
INFERENCE 
 Among 40 patients, 10 patients (25%) were taking vegetarian food and 30 
patients (75%) were taking mixed diet. 
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6. SEASONAL OCCURENCE 
S.No KAALAM (Season) 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Kaar kaalam 
(Mid Aug-Mid Oct) 
0 0% 
2 koothir Kaalam 
(Mid Oct –Mid Dec) 
0 0% 
3 Munpani kaalam 
(Mid Dec-Mid Feb) 
17 42.5% 
4 Pinpani kaalam 
(Mid Feb-Mid Apr) 
23 57.5% 
5 Elavenir kaalam 
(Mid Apr –Mid Jun) 
0 0% 
6 Muthuvenir kaalam 
(Mid Jun –Mid Aug) 
0 0% 
 
 
INFERENCE  
According to paruvakaalam highest incident of 23 cases (57.5%) were noted in 
pinpani kaalam, 17 cases (42.5%) were noted in  Munpani kaalam. 
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7. DISTRIBUTION OF THINAI 
S.No THINAI NUMBER OF CASES 
PERCENTAGE 
(%) 
1 Kurinji 0 0% 
2 Mullai 0 0% 
3 Marutham 0 0% 
4 Neithal 40 100% 
5 Paalai 0 0% 
 
 
INFERENCE 
 According to thinai the highest distribution 100% was noted in neithal nilam. 
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8. DISTRIBUTION OF MUKKUTRAM – VATHAM 
S.No VATHAM NUMBER OF CASES PERCENTAGE (%) 
1 Pranan 0 0% 
2 Abanan 40 100% 
3 Viyanan 40 100% 
4 Uthanan 10 25% 
5 Samanan 40 100% 
6 Nagan 0 0% 
7 Koorman 4 10% 
8 Kirukaran 11 27.5% 
9 Devathathan 12 30% 
10 Thananjeyan 0 0% 
 
 
INFERENCE 
Out of 40 patients Abanan was affected in 40 patients (100%), Viyanan was 
affected in 40 pateints (100%), Uthanan was affected in 10 patients (25%), Samanan 
was affected in 40 patients (100%) Koorman was affected in 4 patients (10%) and 
Kirukaran was affected in 11 patients (27.5%)and Devathathan was affected in 12 
patients(30%). 
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9. DISTRIBUTION OF MUKKUTRAM – PITHAM 
S.No PITHAM 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Analagam 11 27.5% 
2 Ranjagam 8 20% 
3 Saathagam 40 100% 
4 Alosagam 4 10% 
5 Pirasagam 0 0% 
 
INFERENCE 
 Out of 40 patients Analagam was affected in 11 patients (27.5%), Ranjagam 
was affected in 8 patients (20%), Sathagam was affected in 40 patients (100%) and 
Alosagam was affected in 4 patients (10%). 
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10. DISTRIBUTION OF MUKKUTRAM – KABHAM 
S.No KABHAM 
NUMBER OF 
CASES 
PERCENTA
GE (%) 
1 Avalambagam 40 100% 
2 Klethagam 11 27.5% 
3 Pothagam 0 0% 
4 Tharpagam 0 0% 
5 Santhigam 13 32.5% 
 
INFERENCE 
Out of 40 patients, Avalambagam was affected in 40 patients (100%), 
Kiledhagam was affected in 11 patients (27.5%), Santhigam was affected in 13 
patients (32.5%). 
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11. EZHU UDAL THATHUKAL 
S.No 
EZHU UDAL 
THATHUKAL 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Saaram 40 100% 
2 Senneer 8 20% 
3 Oon 13 32.5% 
4 Kozhupu 0 0% 
5 Enbu 13 32.5% 
6 Moolai 12 30% 
7 Sukkilam /Suronitham 0 0% 
 
INFERENCE 
          Out of 40 patients, Saaram was affected in 40 patients (100%), Senneer was 
affected in 8 cases (20%), Oon was affected in 13 cases (32.5%), Enbu was affected 
in 13 cases (32.5%), Moolai was affected in 12 cases (30%). 
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12. EN VAGAI THERVUGAL 
S.No 
EN VAGAI 
THERVUGAL 
NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Naa 2 5% 
2 Niram 8 20% 
3 Mozhi 10 25% 
4 Vizhi 5 12.5% 
5 Sparisam 5 12.5% 
6 Malam 3 7.5 % 
7 Moothiram 35 87.5% 
 
 
INFERENCE 
In Envagai thervu,Naa was affected in 2 patients(5%),Niram was affected in 8 
patients(20), Mozhi was affected in 10 patients(25%), Vizhi was affected in 5 patients 
(12.5%),Sparisam was affected in 5 patients (12.5), Malam was affected in 3 patients 
(7.5%) and Moothiram was affected in 35  patients (87.5%). 
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13. NAADI 
S.No NAADI NUMBER OF CASES PERCENTAGE 
(%) 
1 Vali Azhal 26 65% 
2 Azhal Vali 9 22.5% 
3 Kabha Vatham 3 7.5% 
4 Kabha Pitham 2 5% 
 
 
INFERENCE 
 26 patients (65%) had Vali azhal naadi, 9 patients (22.5%) had Azhal vali  
naadi, 3 patients (7.5%) had kabha vatham, and 2 patients (5%) had Kabha pitha 
naadi. 
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14. NEIKURI 
S.No THATHU NEIKURI 
NUMBER OF 
CASES 
PERCENTAGE 
(%) 
1 Vatha neer Spread like snake 26 65% 
2 Pitha neer Spread like ring 9   22.5% 
3 Kabha neer Spread like pearl 5 12.5% 
 
 
 
INFERENCE 
 26 patients (65%) had vatha neer, 9 patients (22.5%) had Pitha neer, and 5 
patients (12.5%) had Kabha neer. 
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15. CLINICAL FEATURES 
S.No SIGNS & SYMPTOMS NUMBER OF 
CASES 
PERCENTAGE (%) 
1 Flank pain 40 100% 
2 Nausea 2 5% 
3 Vomiting 10 25% 
4 Burning Micturition 20 50% 
5 Dysuria 3 7.5% 
6 Oliguria 12 30% 
7 Fever 5 12.5% 
`8 Retention 0 0% 
9               Hematuria 0 0% 
  
 
INFERENCE 
 Out of 40 patients, 40 patients (100%) had Flank pain, 2 patients (5%) had 
Nausea, 10 patient (25%) had vomiting, 20 patients (50%) had Burning Micturition, 3 
patients (7.5) had Dysuria, 12 patients (30%) had oliguria, 5 patients (12.5%) had 
Fever. 
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16. CLINICAL PROGNOSIS 
S.No SIGNS& 
SYMPTOMS 
BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF 
CASES 
PERCENTAGE 
(%) 
1. Flank pain 40 100% 7 17.5% 
2 Nausea 2 5% 0             0% 
3 Vomiting 10 25% 0 0% 
4 Burning 
Micturition 
20 50% 3 7.5% 
5 Dysuria 3 7.5% 0 0% 
6 Oliguria 12 30% 0 0% 
7 Fever 5 12.5% 0 0% 
 
 
INFERENCE  
               After treatment Flank pain present in 7 patients (17.5%), Burning 
Micturition present in 3 patient (7.5%). no patient have experienced Nausea, 
Vomiting, Dysuria and Fever. 
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17. DISTRIBUTION OF CALCULI BASED ON LOCATION 
SIDE BEFORE TREATMENT AFTER TREATMENT 
NO.OF 
CASES 
PERCENTAGE 
(%) 
NO.OF 
CASES 
PERCENTAGE 
(%) 
Rt – Kidney 10          25% 6 15% 
Lt – Kidney 9 22.5% 4 10% 
Bilateral 20          50% 18 45% 
Ureteral 1          2.5% 0 0% 
 
 
INFERENCE 
Before treatment: 
Out of 40 patients, 20 patients (50%) were having bilateral renal calculi, 10 
patients (25%) were having right renal calculi, and 9 patients (22.5%) were having 
left renal calculi, 1 patient (2.5) had  ureteric calculi. 
After treatment: 
 Out of 40 patients, 18 patients (45%) were having bilateral renal calculi, 6 
patients (15%) having right renal calculi and 4 patient (10%) having left renal calculi. 
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18. GRADING OF RESULTS 
S.No GRADING NUMBER OF CASES PERCENTAGE (%) 
1 Good 13 32.5% 
2 Moderate 21 52.5% 
 
 
Poor 6 15% 
 
 
INFERENCE 
 Out of 40 patients, 13 cases (32.5%) shows good result, 21 cases (52.5%) 
shows moderate result, 6 cases (15%) shows poor result.  
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RESULTS OF PATIENTS BEFORE AND AFTER TREATMENT 
GOVT.SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE, 
CHENNAI-106 
S.No Name of the 
patient 
 
Age / 
Sex 
OP.N
o 
Date of 
Treatment 
Started 
Duration 
of 
medicine 
taken 
Size of 
stone BT 
Prognosis Remarks 
1 Mrs.Srimathy 36/F 6431 03-01-18 7- Weeks Bilateral 
RT 3 
Stones (7.2 
mm), LT 5 
Stones (9.2 
mm) 
Bilateral RT 2 
(5.2 mm), LT 4 
(7 mm) 
Symptoms 
relieved 
2 Miss. Sathya 23/F 6827 10-01-18 7- Weeks LT 6 mm USG Normal Completed 
3 Mrs.Anusuya 50/F 7439 12-01-18 7- Weeks Bilateral 
RT 2  
(4mm), LT 
(3.5mm) 
USG Normal Completed 
4 Mr.Dhanraj 25/M 4743 15-01-18 7- Weeks RT (5 mm) RT (4 mm) Symptoms 
reduced 
5 Mr.Vijay 36/M 1514 25-01-18 7- Weeks RT 2 ( 
5.2mm, 
3.6mm) 
USG Normal Completed 
 
6 Mrs.Mahalakshm
i 
40/F 1949 26-01-18 5- Weeks RT 6mm USG Normal  Completed 
7 Miss.Nandhini 21/F 2913 28-01-18 7- Weeks Bilateral 
RT 6.6mm, 
LT 5.4 mm 
RT 5 mm, LT 
5.4 mm 
Symptoms 
relieved 
8 Mr.Bennet 45/M 4219 30-01-18 7- Weeks RT 2 (2.7 
mm, 3.7 
mm) 
USG Normal Completed 
9 Mr.Ashokraj 52/M 8062 01-02-18 7- Weeks Bilateral 
RT (6 mm), 
LT (6mm) 
Bilateral 2 
(5mm) 
Symptoms 
reduced 
10 Mr.Thamaraiselv
an 
42/M 4980 01-02-18 7- Weeks RT 8mm RT 8 mm Poor 
prognosis 
11 Mr. Sanjay 
gandhi 
40/M 5243 02-02-18 
 
7- Weeks Bilateral 2 
(8 mm) 
RT 7.4mm, LT 
7.8mm 
Advice to 
continue 
medicine 
12 Mr.Kumar 36/M 5651 03-02-18 7- Weeks LT 7-8 mm LT 4 mm Symptoms 
relieved 
 
13 Mrs.Thenkuzhali 32/F 5543 04-02-18 7- Weeks Bilateral 
RT 4mm, 
LT 6mm 
RT 4mm, LT 
4mm 
Symptoms  
Reduced 
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14 Mrs. Thamizhkodi 52/F 5853 08-02-18 7- Weeks Bilateral 
RT  10mm, 
LT 5mm 
RT 9.6 mm, 
LT 5 mm 
Referred 
to 
Urologist 
15 Mr.Abbas 57/M 7414 09-02-18 7- Weeks Bilateral 3 -
4 (3 to 4 
mm) 
USG Normal Completed 
16 Mr.Jaabar 30/M 9245 15-02-18 7- Weeks Bilateral 
RT 6.8 mm, 
LT 6.1 mm 
RT 5.6 mm, 
LT 5 mm 
Symptoms 
relieved 
17 Mrs.Ponnammal 41/F 9272 15-02-18 7- Weeks Bilateral 
RT 4mm, 
LT 2 (3.2 
mm, 4.7 
mm) 
RT (3mm), LT 
4mm 
Symptoms 
reduced 
18 Mr.Prabu 38/M 9420 15-02-18 7- Weeks Bilateral 
RT 4.3 mm, 
LT 5.2mm 
RT 3mm, LT 
3.5mm 
Symptoms 
relieved 
19 Mrs.Rani 59/F 1458 21-02-18 7- Weeks Bilateral  
5.1 mm 
USG Normal Completed 
20 Mr.Suresh 57/M 3714 27-02-18 7- Weeks RT 5.7 mm RT 3.9mm Symptoms 
relieved 
21 Mrs.Selvi 33/F 3716 28-02-18 7- Weeks LT 5.4 mm USG Normal Completed 
22 Mrs.Valli 42/F 3715 28-02-18 7- Weeks Bilateral 
RT 9.1 mm, 
LT 6 mm 
Bilateral RT 
9.1 mm, LT 6 
mm 
Poor 
prognosis 
23 Mr.Manimaran 45/M 4904 
 
01-03-18 7- Weeks LT 4.6 mm USG Normal Completed 
24 Mrs. Krishna 
moorthy 
45/M 4910 01-03-18 7- Weeks LT 2 (17.8 
mm, 8.3 
mm) 
LT 2 (17.8 
mm, 8 mm) 
Referred 
to 
Urologist 
25 Mrs.Manimegala
i 
38/F 4012 01-03-18 7- Weeks Bilateral 
RT 3 (3.5, 
3mm), LT 2 
(3mm) 
RT 2 (3mm), 
LT 3mm 
Symptoms 
relieved 
 
 
 
 
26 Mr.Mariyappan 43/M 4011 01-03-18 7- Weeks Bilateral 
RT 2 (4.5, 
5mm), LT 
8mm,  
RT 2 
(3.5mm,4mm), 
LT 3.5mm) 
Symptoms 
reduced 
27 Mrs.Sanaa 32/F 5292 05-03-18 7- Weeks LT 5.2 mm USG Normal Completed 
28 Mr.Immugan 34/M 5313 05-03-18 7- Weeks Bilateral 3 
(3.5mm) 
RT 3 (3.5mm), 
LT 2 (3.5mm) 
Symptoms 
reduced 
29 Mrs.Kaaleeshwar
i 
53/F 5516 06-03-18 7- Weeks LT 5mm USG Normal Completed 
30 Mr.Shanmugam 48/M 6333 08-03-18 7- Weeks Bilateral 
RT 4 
(5.5mm), 
LT 3 
(5.2mm) 
RT 4(3mm), 
LT 3 (4mm) 
Symptoms 
reduced 
31 Mr.Singaraj 48/M 6332 08-03-18 7- Weeks RT 2 (8, 
5mm) 
RT 2 (5, 4mm) Symptoms 
reduced 
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32 Mrs.Shanthi 52/F 7897 13-03-18 7- Weeks Bilateral 2 
(5.6 to 6.2 
mm) 
Bilateral 5 mm Symptoms 
reduced 
33 Mr. Sekar 49/M 8175 14-03-18 7- Weeks RT 6 mm USG Normal Completed 
34 Mr.Ravi 42/M 1921 14-03-18 7- Weeks 1.6x0.6x0.1 
size 
Ureteric 
calculi 
Stone expelled, 
USG Normal 
Completed 
35 Mr.Muralikumar 32/M 3214 15-03-18 7- Weeks BilateralRT 
4mm, LT 2 
(4.2mm,4.7 
mm) 
RT 3mm, LT 2 
(3 mm) 
Symptoms 
reduced 
36  Mr.Karthikeyan 40/M 6637 17-03-18 7- Weeks RT 5.7 mm RT 3 mm Symptoms 
relieved 
37 Mr. Vanagamudi 37/M 3912 22-03-18 7- Weeks Bilateral 
RT 4.3mm, 
LT 5.2mm 
Bilateral  3mm Symptoms 
reduced 
38 Mr. Madhan 35/M 1571 24-03-18 7- Weeks RT 8mm RT 6.8 mm Advice to 
continue 
medicine 
39 Mr. Manikandan 42/M 1570 24-03-18 7- Weeks LT 6.7 mm LT 5.6 mm Symptoms 
reduced 
40 Mrs. Usha 58/F 4913 30-03-18   7- Weeks LT 7.2 mm LT 5.6 mm Symptoms 
relieved 
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                                   LABORATORY INVESTIGATION REPORT 
BEFORE TREATMENT 
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 P L E ½ hr 1 hr       
1 6431 36/F 8600 57 41 2 12 26 10.6 32 0.8 Nil Nil Opc 
2 6827 23/F 9200 64 33 3 15 35 10.8 28 1.0 Nil Nil Opc 
3 7439 50/F 8700 63 33 4 2 5 13.6 26 0.7 Nil Nil Nil 
4 4743 25/M 7300 49 46 5 16 35 14 29 0.8 Nil Nil Opc 
5 1514 36/M 8900 59 36 5 7 16 10.6 26 0.6 + Nil Opc 
6 1949 40/F 8600 62 36 2 20 42 10.6 32 0.8 Nil Nil Oec 
7 2913 21/F 8200 49 51 0 5 12 11.8 28 0.4 Nil Nil Nil 
8 4219 45/M 6600 58 39 3 4 10 11.2 22 0.7 Nil Nil Nil 
9 8062 52/M 7900 62 30 8 6 14 9.4 21 0.3 Nil Nil Nil 
10 4980 42/M 9900 50 49 1 11 30 14.8 24 0.4 Nil Nil Opc 
11 5243 40/M 7500 61 35 4 12 26 12.5 30 0.7 Nil Nil Opc 
12 5651 36/M 9600 60 39 1 4 10 13 28 1.0 Nil Nil Oec 
13 5543 32/F 9500 49 48 3 7 17 10.8 32 0.6 + Nil Oec 
14 5853 52/F 7500 63 33 4 5 12 9.6 23 0.7 Nil Nil Nil 
15 7414 57/M 8800 59 36 5 21 40 12.2 23 0.9 Nil Nil Opc 
16 9245 30/M 8900 61 37 2 6 10 13 21 0.7 Nil Nil Nil 
17 9272 41/F 9200 67 30 3 15 32 14 24 0.3 Nil Nil Oec 
18 9420 38/M 8100 61 34 5 8 17 11.2 26 0.8 Nil Nil Oec 
19 1458 59/F 8700 70 28 2 10 22 13 34 1.1 + Nil Opc 
20 3714 57/M 7400 63 33 4 5 11 14.6 32 1.0 Nil Nil Opc 
21 3716 33/F 8300 55 44 1 3 7 11.4 26 0.6 Nil Nil Nil 
22 3715 42/F 7400 68 28 4 6 12 12.4 27 0.7 Nil Nil Opc 
23 4904 45/M 8900 62 35 3 3 7 12.6 31 1.0 Nil Nil Oec 
24 4910 45/M 8300 59 35 6 31 72 14.8 32 0.8 Nil Nil Oec 
25 4012 38/F 9100 67 28 5 5 13 12.6 34 0.8 Nil Nil Opc 
26 4011 43/M 9800 54 38 8 17 39 15 40 2.0 + Nil Opc 
27 5292 32/F 7700 56 42 2 5 12 9.6 34 1.2 Nil Nil Nil 
28 5313 34/M 7200 63 31 6 14 32 13.3 26 0.8 Nil Nil Opc 
29 5516 53/F 9500 64 35 1 5 11 10.6 31 0.7 Nil Nil Nil 
30 6333 48/M 8900 63 31 6 4 10 14.6 30 1.1 + Nil Oec 
31 6332 48/M 8200 61 36 3 10 15 14.6 36 1.0 Nil Nil Opc 
32 7897 52/F 7700 61 35 4 5 13 12.8 21 0.8 Nil Nil Oec 
33 8175 49/M 9900 54 42 4 2 6 10.4 36 0.9 Nil Nil Nil 
34 1921 42/M 8600 66 32 2 6 18 13.8 29 0.6 Nil Nil Nil 
35 3214 32/M 10000 68 29 3 4 10 14.2 28 0.4 Nil Nil Nil 
36 6637 40/M 9600 71 29 0 2 5 13.4 22 0.7 + Nil  Oec 
37 3912 37/M 8400 59 38 3 12 28 14.2 29 0.6 Nil Nil Nil 
38 1571 35/M 8400 55 41 4 2 6 12.5 28 0.9 Nil Nil Opc 
39 1570 42/M 7600 59 36 5 4 12 13 34 0.6 Nil + Oec 
40 4913 58/F 9600 67 28 5 16 40 12.5 28 0.5 Nil Nil Nil 
 
TC – Total count, DC – Differential count, P – Polymorphs, L – Lymphocyte, 
E – Eosinophil, ESR – Erythrocyte Sedimentation Rate, Oec – Occasional epithelial 
cells, Opc – Occasional pus cells, Alb – Albumin, Sug – Sugar, Dep – Deposit
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       LABORATORY INVESTIGATION REPORT 
AFTER TREATMENT 
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 P L E ½ 
hr 
1 
hr 
      
1 6431 36/F 9700 63 33 4 5 10 11.6 29 0.8 Nil Nil Nil 
2 6827 23/F 8400 66 34 0 4 8 12.9 24 0.9 Nil + Opc 
3 7439 50/F 8900 71 28 1 6 15 14.6 27 0.6 Nil Nil Nil 
4 4743 25/M 8500 62 35 3 10 20 14 26 0.8 Nil Nil Nil 
5 1514 36/M 9300 63 34 3 4 10 11.6 27 0.6 Nil Nil Nil 
6 1949 40/F 9600 65 32 3 3 7 12.6 30 0.7 + Nil Oec 
7 2913 21/F 8700 61 35 4 10 25 12.8 28 0.9 Nil Nil Nil 
8 4219 45/M 8500 65 32 3 2 5 13.2 30 0.7 Nil Nil Nil 
9 8062 52/M 8700 63 31 6 3 10 14.4 29 0.8 Nil Nil Nil 
10 4980 42/M 9100 59 36 5 12 30 14.6 23 0.5 Nil Nil Nil 
11 5243 40/M 8700 62 35 3 12 28 13.5 28 0.8 Nil Nil Opc 
12 5651 36/M 9700 65 32 3 7 15 13 25 0.9 Nil Nil Nil 
13 5543 32/F 9500 62 34 4 2 5 11.8 27 0.8 Nil Nil Nil 
14 5853 52/F 8900 61 36 3 2 12 9.8 26 0.7 Nil Nil Nil 
15 7414 57/M 9400 57 39 4 15 20 13.1 31 0.8 Nil Nil Nil 
16 9245 30/M 8800 60 37 3 4 7 13.2 20 0.7 Nil Nil Nil 
17 9272 41/F 9900 65 30 5 6 15 13 26 0.9 Nil Nil Oec 
18 9420 38/M 8800 67 33 0 5 12 14.2 25 0.6 Nil Nil Nil 
19 1458 59/F 8900 60 37 3 9 21 13.4 25 0.8 Nil Nil Opc 
20 3714 57/M 9200 69 27 4 2 10 13 34 0.9 Nil Nil Nil 
21 3716 33/F 9800 65 33 2 3 13 12.4 24 0.7 Nil Nil Nil 
22 3715 42/F 8600 62 32 5 6 12 14 26 0.9 Nil Nil Nil 
23 4904 45/M 8500 66 33 1 3 7 13.6 25 1.0 Nil Nil Nil 
24 4910 45/M 8800 60 35 5 17 36 14.0 21 0.7 Nil Nil Nil 
25 4012 38/F 9900 59 37 4 5 9 13.6 29 0.8 Nil Nil Nil 
26 4011 43/M 9900 56 40 4 5 11 13.1 36 1.7 Nil Nil Nil 
27 5292 32/F 9100 59 35 6 4 12 13.2 30 1.0 Nil Nil Nil 
28 5313 34/M 7900 60 37 3 10 22 12 24 0.8 Nil Nil Opc 
29 5516 53/F 8700 69 28 3 4 12 10.9 26 0.7 Nil Nil Nil 
30 6333 48/M 8400 61 35 4 8 22 14.4 30 1.0 Nil Nil Nil 
31 6332 48/M 8900 63 34 3 7 12 14.5 31 1.1 Nil Nil Opc 
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32 7897 52/F 8900 61 36 3 5 14 12.9 24 0.7 Nil Nil Nil 
33 8175 49/M 9400 58 38 4 2 6 12.1 22 0.8 Nil Nil Nil 
34 1921 42/M 8700 60 37 3 6 14 10.8 26 1.1 Nil Nil Nil 
35 3214 32/M 10300 61 36 3 6 12 14.6 38 0.7 Nil Nil Nil 
36 6637 40/M 8300 68 29 3 5 15 13.8 22 0.8 Nil Nil Nil 
37 3912 37/M 8600 53 41 6 7 16 13.2 24 0.8 Nil Nil Nil 
38 1571 35/M 9700 66 30 4 2 8 14.5 28 0.9 Nil Nil Nil 
39 1570 42/M 8000 65 32 3 4 10 13.4 35 0.7 Nil Nil Nil 
40 4913 58/F 9700 69 28 3 5 12 12 26 0.7 Nil Nil Nil 
 
TC – Total count, DC – Differential count, P – Polymorphs, L – Lymphocyte, E – Eosinophil, 
ESR – Erythrocyte Sedimentation Rate, Oec – Occasional epithelial cells, Opc – Occasional pus 
cells, Alb – Albumin, Sug – Sugar, Dep – Deposits 
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DISCUSSION 
Urinary calculi are known to mankind since antiquity. The earliest recorded example 
being bladder and kidney stones detected in Egyptian Mummies dated to 4800 B.C. Kalladaippu 
is a common disease pertaining to the kidney. Large populations are suffering from this disease. 
In spite of new approach in diagnosis and management, it still continues to cause significant 
morbidity, with a high tendency of recurrences. Hence with the help of trial medicine from 
Siddha system, results and observations are noted for this study. 
 The patients were examined base on Siddha and as well as modern aspects. All the 
necessary investigations were made during the study. The results obtained from their studies 
were discussed below for better conclusion. 
 Trial medicine administered was Kalladaippu Chooranam – 1gm 2 times a day with 
honey after food for 48 days. 
40 cases were selected in the outpatient ward of Aringar  Anna Government Hospital of Indian 
Medicine attached to Government Siddha Medical College, Arumbakkam ,Chennai -106 during 
the period of 2015-2018.All necessary investigations were carried out to all patients and trail 
medicine were given. 
 IEC, CTRI: 
Study Design 
The study was approved by Institutional Ethics Committee (IEC) and the approval 
number is GSMC-CH-ME-5/2016/001.It was registered in Clinical TrialsRegistry – India        
( CTRI ) and the reference number is CTRI/2018/03/012767. 
Population and sample: 
The population consists of all patients satisfying the inclusion and exclusion criteria 
mentioned below. Sample consists of VATHA KALLADAIPPU patients who were attending the 
OPD of Arignar Anna Hospital, Arumbakkam, Chennai – 106. 
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Sample Size: 
The trial size will be 40 patients. 
DRUG AUTHETICATION: 
I have got a drug authentication of minerals like padikaram, venkaram, Savukaaram, 
Induppu from Department of chemistry and freshly specimens of  herbals like Musa paradisiacal,  
Borassusfiabellifer , Achyranthesaspera were collected from their nativity  and authentication 
from the Department of  Pharmacognosy  Siddha Central  Research  Institute,  Arumbakkam 
Chennai-106. 
IAEC: 
IAEC/NO: LI/16/CLBMCP/2017 
TOXICITY STUDY: 
ACUTE TOXICITY: 
Acute and sub acute toxicity studies were conducted on experimental rats at C.L .Baid 
Metha College of Pharmacy, Chennai, Tamilnadu.Acute toxicity study of the drug 
KalladaippuChooranam with Honey was carried out as the OECD guideline - 423 (Organisation 
to Econamic Co-operation and Development).The acute toxicity study of my trial medicine was 
studied and the drug was proved safer for long term administration, as it did not exhibit any 
significant toxicity at 2000 mg / kg body weight. 
SUB ACUTE TOXICITY: 
Sub acute toxicity study as per the guideline of – 407. Under the dosage of trial medicine 
200mg / kg (Low dose), 400mg / kg (High dose) it did not exhibit any significant. 
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PHARMACOLOGICAL ACTIVITY: 
The pharmacology studies of trial medicine Kalladaippu Chooranam showed significant 
Lithotriptic action in wistarrats.The Lithotriptic activity of Kalladaippu Chooranam was carried 
out in wistar rats through Ethylene Glycol-induced urolithiasis method. Then trial medicine was 
administrated shows a potent Lithotriptic activity during the studies.The result of preclinical 
screening, the result of chemical analysis, Toxicological studies, Pharmacological studies were 
shown in annexure. 
PRE CLINICAL SCREENINGS: 
PHSIOCHEMICAL ANALYSIS: 
Loss on Drying (at 105
0
C) was 8.3%. 
The total   ashvalue 73.53%,  
Acid insoluble ash 17.96% 
Water soluble ash 50.55% 
Water soluble extraction 72.15%  
                Alcohol soluble extraction 2.96% 
BIOCHEMICAL ANALYSIS: 
Kalladaippu Chooranam contains -Chlorides, Phosphate, Sulphate, and Iron.  
CLINICAL STUDY: 
All the necessary investigations were carried out to all patients and trial medicine were 
given. Weekly once follow up were done. Total duration of treatment ranges from 48 days. All 
the patients were strictly advised to follow diet restriction and peaceful life style to normalize the 
immune mechanism. 
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GENDER DISTRIBUTION: 
From selected 40 cases of 60% were males and 40% were females Urolithiasis is most 
commonly affected in male. 
AGE DISTRIBUTION: 
Out of 40 cases 14 patients (35%) were between 31 – 40 years, 13 patients (32.5%) were 
between 41 – 50 years, 9 patients (22.5%) were between 51 – 60 years and 4 patients (10%) were 
between 21-30 years.High incidences of cases were noted in age ranging of 31 – 40 years during 
the studies. The disease is more common in 3
rd
 and 4
th
 decade. 
SEASONAL INCIDENCE: 
According to Paruvakaalam highest incidences of 57.5% were noted in Pinpanikaalam 
and 42.5% cases were noted in Munpanikaalam. When clinical trials of 40 cases were enquired 
about the seasonal link, most of the cases were in PinpaniKaalam due to seasonal variation. 
OCCUPATIONAL STATUS: 
 From selected 40 cases, 13 patients (32.5%) were house Officer worker, 11 patients 
(27.5%) were housewives, 5 patients (12.5%) were businessman,1 patients(2.5%) was Student 10 
patients (25%) were others.Mixedcatagories of people are affected from Office workers, 
housewife. 
SOCIO ECONOMIC STATUS: 
Recording Socio Economic Status 22 patients (55%) were low income and 13 cases 
(32.5%) from middle income and 5 cases (12.5%) from high income. The people living in poor 
Socio Economic Status were more affected because of life style and environmental factors. 
DIET REFERENCE: 
Out of 40 cases, most of the cases 30 (75%) were taken mixed diet and 10 cases (25%) 
had vegetarian diet only. 
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THINAI DISTRIBUTION: 
 According to the study, 40 cases (100%) were from Neithal thinai. Thinai in which 
the patients live in one of the major extrinsic factor responsible for urinary lithiasis. Siddha 
Maruthuvanga Churukkam explains that in Neithalnilam, Vali Azhal in its power. 
CLINICAL MANIFESTATION: 
In respect of the patients with Kalladaippu, the clinical manifestation of Flank Pain were 
present in 40 cases (100%), Burning micturation had present in 20 cases (50%), Oliguria were 
present in 12 cases (30%), Nausea were present in 2 cases (5%), Fever in 5 patients (12.5%) and 
Vomitting were present in10 cases (25%), Dysuria in 3 cases (7.5%) and Oliguria in 12 cases 
(30%).   
 
MUKKUTRAM: 
 
DISTRIBUTION OF VATHAM: 
According to classification of Vatham, derangement of Abanan, Viyanan, Uthhanan, 
Samanan, Kirukaran and Devathathan. 40 patients (100%) was affected with Abanan, 40 patients 
(100%) was affected with Viyanan,and 40 patients was affected with Samanan,10 patients (25%) 
was affected with Uthanan,Koorman was affected with 4 patients (10%) , 11 patients (27.5%) 
was affected with Kirukaran,12 patients (15%) was affected with Devathathan and none affected 
with Pranan, Naagan ,korman and Thananjeyan. 
 Affected Abanan produced Burning micturition , constipation dysuria and oliguria 
 Affected Viyanan produced (pain) tenderness from loin to groin. 
 Affected Uthanan produced nausea and vomiting. 
 Affected samanan due to other factor. 
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 Affected Koorman due to dullness of vision. 
 Affected kirukaran produced loss of appetite 
 Affected Devathathan produced insomnia. 
 
DISTRIBUTION OF PITHAM: 
According to Pitham 40 cases (100%) were affected Saathagam, 11 cases (27.5%) was 
affected with Analagam, 8 cases (20%) was affected with Ranjagam,Alosagam was affected with 
4 patients(10%). 
 Affected Analagam produced loss of appetite. 
 Affected Ranjagam produced pallor of skin, eye and reduced haemoglobin. 
 Affected Saathagam due to unable to perform desired work. 
 Affected Alosagam due to dullness of vision. 
DISTTRIBUTION OF KABAM: 
According to the study, 40 cases (100%) affected by Avalambagam, 11 cases (27.5%) 
affected by Kelathagam, 13 cases (32.5%) affected by Santhigam. 
 Affected   Avalambagam due to other factors. 
 Affected   Kelathagam due to loss of appetite and indigestion. 
 Santhigamiyam gives stability, lubrication and movements of joints.  
 Affected   Santhigam produced low back pain. 
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EZHU UDAL KATTUGAL: 
From the above chart, we observe that Saaram, were affected in all the patients (100%), 
Senneer was affected in 8 cases (20%), Oon was affected in 13 cases (32.5%), Enbu was affected 
in 13 cases (32.5%),Moolai was affected in 12 cases (30%),  None affected with Kozhupu and 
Sukkilam / Suronitham. 
ENVAGAI THERVUGAL: 
According to Envagaithervugal, Naa was affected in 2 cases (5%), Niram was affected in 8 
patients (20%), Mozhi was affected in 10 cases (25%),Vizhi was affected in 5 patients (12.5%), 
Sparisam was affected in 5 patients (12.5%), Malam was affected in 3 patients (7.5%), 
Moothiram was affected in for all the 35 patients (87.5%). 
 Naa was affected due to anaemia. 
 Niram was affected due to anaemia (pale colour). 
 Vizhi was affected had dullness of vision. 
 Mozhi was affected low pitched sound. 
 Sparisam was affected due to Fever, tenderness pain. 
 Malam was affected due to constipation. 
 Moothiram was affected due Burning micturation, Oliguria and Dysuria. 
NAADI: 
Out of 40 patients, 26 patients (65%) had VathaAzhal, 9 patients (22.5%) had AzhalVali, 
3 patients (7.5%) had KabhaVatham, 2 patients (5%) had KabhaPitham 
NEIKURI: 
Out of 40 patients (65%) had VathaNeer, 9 patients (22.5%) had PithaNeer and 5 patients 
(12.5%) had KabhaNeer. 
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CLINICAL PROGNOSIS: 
The clinical signs and symptoms were improved after treatment, `showing only 7 cases 
(17.5%) had Flank pain, 3 cases (7.5%) had Burning micturation. 
INVESTICATION: 
In Blood tests, TC, DC, ESR, Hb% serum creatinine, blood urea were investigated. 
 
URINE: 
Albumin, Sugar, Deposits were investigated. 
SPECIAL INVESTICATION: 
USG- abdomen and pelvis is advised for all the patients to confirm the diagnosis.After 
confirming the diagnosis, the patients were given the trial medicine and instructed to follow the 
diet and other restrictions based on Siddha system. 
BIO STATISTICAL STUDY: 
Since the p value C.I: 95%, *P<0.05; **P<0.01 is significant in all clinical 
manifestations. So there is significant reducing of clinical manifestations among the patients for 
the treatment of Vatha Kalladaippu. Hence it is concluded that the treatment was effective and 
significant. 
DISTRIBUTION OF CALCULI BASED ON LOCATION: 
Since the p value C.I: 95%, *P<0.05; **P<0.01 is significant in all sides. So there is a 
significant changes grade of pain among the patients for the treatment of Vatha Kalladaippu. 
Hence it is concluded that the treatment was effective and significant. 
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OVER ALL RESULT: 
Out of 40 patients, 13 cases (32.5%) shows good result, 21 cases (52.5%) shows 
moderate result, 6 cases (15%) shows poor result. 
 
 
 
SUMMARY 
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SUMMARY: 
The clinical study on VATHA KALLADAIPPU was carried out in post graduate 
department of pothumaruthuvam, Govt. Siddha Medical College, Aringar Anna Hospital, 
Chennai 106. During the period of 2015-2018.A total of 40 patients was treated in the out patient 
department. The clinical and pathological assessment was carried out on the basis of Siddha and 
Modern aspects.All the patients were treated with KALLADAIPPU CHOORANAM with 
Honey 1g b.d, daily after food for duration of 48 days. 
 I like to summarize this study with the following highlights. 
 Males are more prone to get kalladaippu than females according to my studies, males 
were affected with 60%. 
 In age distribution, age groups between 31-40 yrs of people are more affected which is 
35%. 
  Office workers (32.5%) and House wives (27.5%) occupy the first two places in 
occupational classification. 
 Most of the patient had mixed diet (75%). 
 Higher incidences of cases were noted in Pinpanikalam (Mid Feb – Mid Apr) which is 
57.5%. 
 Most of the patients were from Neithalthinai (100%). 
 In Vali, Abanan (100%), Viyanan (100%), Uthanan (25%), Samanan (100%), Koorman 
(10%), Kirukaran (27.5%), Devathathan (30%) was affected. 
 In Azhal, Analagam (27.5%), Ranjagam (20%), Saathagam (100%), Alosagam (10%) 
was affected. 
 In Iyyam, Avalambagam (100%), Kelathagam (27.5%), Santhigam (32.5%) was 
affected.  
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 In the disturbance of Ezhu udal thathukkal, 100% saaram, 20% senneer, 32.5% Oon, 
32.5% enbu and Moolai 25% were affected. 
 In Envagaithervu, 5% Naa, 20% Niram, 25% Mozhi, 12.5% Vizhi, 12.5% Sparisam, 
7.5% Malam, 87.5% Moothiram were affected.  
 In Naadi, most of the patients having vali azhal naadi (65%). 
 In Neikuri examination 65% were having vatha neer. 
 Among the patients, 100% had flank pain, 50% had burning Micturition, 5% had 
nausea, 12.5% had fever, Vomiting 25%, Oliguria 30% and 5% had Dysuria. 
 Most of the patients had stone in both sides of the kidney (45%). 
 The Toxicological studies of the trial medicine reveal no toxicity. 
 The pharmacological studies reveal that, the TRIAL MEDICINE has LITHOTRIPTIC 
ACTIVITY. 
 Bio-statistical analysis of the clinical trial reveals significant p value <0.05, <0.01 and 
concludes that the treatment is effective and significant. 
 After treatment with this trial medicine, most of the symptoms like loin pain, burning 
Micturition and Dysuria are relieved. The trial medicine shows 32.5% good result and 
52.5% moderate result. 
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CONCLUSION 
Kalladaippu is a common disorder due to dearrangement of pitha kutram. The dearranged pitham 
is settled down by the trial medicine by its thuvarpu suvai, on Oppurai Maruthuvam. 
 Most of the cases noted in Pinpanikalam and munpanikalam in my clinical trial. So, 
people should take all preventive measures during this period and take enough water. 
  The Kalladaippu chooranam no toxicity in the preclinical studies and hence proved to 
be safe for human administration. 
  Pharmacological study reveals that the trial medicines possess lithotriptic activity. 
 During clinical trial, no adverse reactions or complications were observed. 
 The cast of the TRIAL MEDICINE is less also the palatability is alsoacceptable for 
consume by the patients.  
 The trial medicine Kalladaippu chooranam showed good results with relieving 
symptoms in almost 85% patients. 
 Once again Siddha medicine proves itself as a great boon to mankind. 
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 ACUTE ORAL TOXICITY STUDY OF KALLADAIPPU CHOORANAM 
(OECD GUIDELINE – 423) 
Introduction: 
 The acute toxic class method is a stepwise procedure with the use of 3 animals 
of a single sex per step. 
 Depending on the mortality and/or the moribund status of the animals, on 
average 2-4 steps may be necessary to allow judgement on the acute toxicity of 
the test substance.  
 This procedure is reproducible, uses very few animals and is able to rank 
substances in a similar manner to the other acute toxicity testing methods.  
 The acute toxic class method is based on biometric evaluations with fixed 
doses, adequately separated to enable a substance to be ranked for classification 
purposes and hazard assessment.  
 In principle, the method is not intended to allow the calculation of a precise 
LD50, but does allow for the determination of defined exposure ranges where 
lethality is expected since death of a proportion of the animals is still the major 
endpoint of this test.  
 The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%.  
 The use of a selection of pre-defined doses, regardless of test substance, with 
classification explicitly tied to number of animals observed in different states 
improves the opportunity for laboratory to laboratory reporting consistency and 
repeatability.  
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Principle of the Test:  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. 
Absence or presence of compound-related mortality of the animals dosed at one step 
will determine the next step, i.e. 
− no further testing is needed 
− dosing of three additional animals, with the same dose  
− dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the test substance 
to one of a series of toxicity classes. 
Methodology: 
Selection of Animal Species  
 The preferred rodent species is the wistar albino rat, although other rodent 
species may be used. Healthy young adult animals are commonly used laboratory 
strains should be employed. Females should be nulliparous and non-pregnant. Each 
animal, at the commencement of its dosing, should be between 6 to 8 weeks old and the 
weight (150-200gm) should fall in an interval within±20 % of the mean weight of any 
previously dosed animals.  
Housing and Feeding Conditions 
 The temperature in the experimental animal room should be 22ºC + 3ºC.  
Although the relative humidity should be at least 30% and preferably not exceed 70% 
other than during room cleaning the aim should be 50-60%. Lighting should be 
artificial, the sequence being 12 hours light, 12 hours dark. For feeding, conventional 
laboratory diets may be used with an unlimited supply of drinking water. Animals may 
be group-caged by dose, but the number of animals per cage must not interfere with 
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clear observations of each animal. 
Preparation of animals:   
The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization to 
the laboratory conditions 
Test Animals and Test Conditions:  
 Sexually mature Female Wistar albino rats (150-200gm) were obtained 
fromkings institute, Chennai.All the animals were kept under standard environmental 
condition (22±3°C).  The animals had free access to water and standard pellet diet (Sai 
meera foods, Bangalore). 
Preparation of animals:  The animals are randomly selected, marked to permit 
individual identification, and kept in their cages for at least 7 days prior to dosing to 
allow for acclimatization to the laboratory conditions 
Preparation for Acute Toxicity Studies 
 Rats were deprived of food overnight (but not water 16-18 h) prior to 
administration of the, KALLADAIPPU CHOORANAM 
The principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of the animals and the study design 
IAEC No: XLVIII/01/CLBMCP/2016 
Test Substance  : KALLADAIPPU CHOORANAM 
Animal Source  : Kings institute, Chennai.   
Animals   : Wister Albino Rats (Female-3+3) 
Age    : >6 weeks 
Body Weight on Day 0 :180-300 gm. 
Acclimatization  : Seven days prior to dosing. 
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Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number and individual   
     marking by using Picric acid. 
Numberofanimals  : 3 Female/group,  
Routeofadministration :   Oral  
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,  
Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages 
    provided with bedding of husk. 
Housing temperature : between 22ºC + 3ºC.  
Relative humidity  : between 30% and 70%, 
Air changes    : 10 to 15 per hour and  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 14 Days 
Administration of Doses:  
 KALLADAIPPU CHOORANAM was suspended in water and administered to 
the groups of wistar albino rats in a single oral dose by gavage using a feeding needle. 
The control group received an equal volume of the vehicle. Animals were fasted 12 
hours prior to dosing. Following the period of fasting, the animals were weighed and 
then the test substance was administered. Three Female animals are used for each 
group. The dose level of 5, 50,250 and 500 mg/kg body weight was administered 
stepwise. After the substance has been administered, food was withheld for a further 3-
4 hours. The principle of laboratory animal care was followed. Observations were made 
and recorded systematically and continuously as per the guideline after substance 
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administration. The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements.Finally, the number of  
survivors was noted after 24 hrs and these animals were then monitered for a further 14 
days and observations made daily. The toxicological effect was assessed on the basis of 
mortality. 
Observations:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the 
first 4 hours, and daily thereafter, for a total of 14 days, except where they need to be 
removed from the study and humanely killed for animal welfare reasons or are found 
dead. It should be determined by the toxic reactions, time of onset and length of 
recovery period, and may thus be extended when considered necessary. The times at 
which signs of toxicity appear and disappear are important, especially if there is a 
tendency for toxic signs to be delayed. All observations are systematically recorded 
with individual records being maintained for each animal. 
Observations include changes in skin and fur, eyes and mucous membranes, and 
also respiratory, circulatory, autonomic and central nervous systems, and somatomotor 
activity and behavior pattern. Attention was directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. The principles and criteria 
summarized in the Humane Endpoints Guidance Document taken into consideration. 
Animals found in a moribund condition and animals showing severe pain or enduring 
signs of severe distress was humanly killed. When animals are killed for humanreasons 
or found dead, the time of death was recorded. 
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Acute oral toxicity study of KALLADAIPPU CHOORANAM 
Table 1: Dose finding experiment and its behavioral Signs of acute oral 
Toxicity 
 
Observation done: 
SL 
Group 
CONTROL 
Observation SL 
Group 
TEST 
GROUP 
Observation 
1 Body weight Normal 1 Body weight 
Normally increased 
 
2 
Assessments of 
posture 
Normal 2 
Assessments 
of posture 
Normal 
3 
Signs of Convulsion 
Limb paralysis 
Normal 3 
Signs of 
Convulsion 
Limb 
paralysis 
Absence of sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color 
No significant 
color change 
7 
Change in 
skin color 
No significant color 
change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation 
Normal 
 
9 Defecation 
Normal 
 
10 Sensitivity response Normal 10 
Sensitivity 
response 
Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 
Muscle 
gripness 
Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
 
Behaviour: 
 The animals will be observed closely for behaviour in the first four hours which  
includes abnormal gait, aggressiveness, exophthalmos, ptosis, akinesia, catalepsy, 
convolusion, excitation, head twitches, lacrimation, loss of corneal reflex, loss of 
traction, piloerection  reactivity of touch, salivation, scratching, sedation, chewing,  
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head movements, sniffing, straub, tremor and writhes, diarrhea, leathery, sleep and 
coma. 
Body Weight:  
Individual weight of animals was determined before the test substance was 
administered and weights will be recorded at day 1, 7, and 14 of the study. Weight 
changes were calculated and recorded. At the end of the test, surviving animals were 
weighed and humanly killed. 
Food and water Consumption: 
 Food and water consumed per animal was calculated for control and the treated 
dose groups.  
Mortality: 
Animals were observed for mortality throughout the entire period. 
Results: 
 All data were summarized in tabular form, (Table-1-4) showing for each test 
group the number of animals used, the number of animals displaying signs of toxicity, 
the number of animals found dead during the test ,description of toxic symptoms,, 
weight changes, food and water intake. 
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No of animals in each group:3 
Table 2 (Observational study Results) 
N
o 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
1. 
Contr
ol 
+ - - + - + - - - - - - - - - - - - - - 
2. 
 
500 
mg/kg 
 
+ - - + - + - - - - - - - - - - - - - - 
 
1..Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. 
Touch Response 7. Decreased Motor Activity 8.Tremors 9.Convulsions 10. Muscle 
Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14.Analgesia 15.Lacrimation 
16.Exophthalmos 17.Diarrhea 18. Writhing  
19. Respiration 20. Mortality. 
(+  Present, -  Absent) 
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Table 3 ( Body Weight Observation) 
DOSE 
 
DAYS 
1 7 14 
CONTROL 186.6± 2.75 189.2± 3.87 194.2 ± 7.62 
500 mg/kg 182.5± 4.08 184.2± 2.16 187.4 ± 2.67 
P value (p)* NS NS NS 
 
Table 4 Water intake (ml/day) of Wistar albino rats group exposed to 
(KALLADAIPPU CHOORANAM): 
 
DOSE 
 
DAYS 
1 6 14 
CONTROL 28.5 ± 
2.74 
30.0± 9.13 32.4± 3.13 
500 mg/kg 30.4±2.33 36.6±1.11 38.9± 2.19 
P value (p)* NS NS NS 
N.S- Not Significant,**(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table 5: Food intake (gm/day) of Wistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
DOSE 
 
DAYS 
1 7 14 
CONTROL 23.56±3.36 28.60±2.42 31.61±5.46 
500 mg/kg 22.42±1.64 29.31±1.22 32.22±3.24 
P value (p)* NS NS NS 
 
REPEATED DOSE 28-DAY ORAL TOXICITY STUDY OF 
KALLADAIPPU CHOORANAM 
Test Substance  : KALLADAIPPU CHOORANAM 
Animal Source  : Kings institute, Chennai.   
Animals   : Wister Albino Rats (Male -24, and Female-24) 
Age    : >6 weeks 
Body Weight    : 180-300 gm. 
Acclimatization  : Seven days prior to dose. 
Veterinary examination : Prior and at the end of the acclimatization period. 
Identification of animals : By cage number, animal number   and    individual  
 marking by using    Picric acid 
Diet    : Pellet feed supplied by Sai meera foods Pvt Ltd,       
      Bangalore 
Water    : Aqua guard portable water in polypropylene bottles. 
Housing & Environment : The animals were housed in Polypropylene cages  
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      provided with bedding of husk. 
Housing temperature : between 22ºC +3ºC.  
Relative humidity  : Between 30% and 70%, 
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12:12 hours. 
Duration of the study : 28 Days. 
Table 5  
 
Methodology 
Randomization, Numbering and Grouping of Animals: 
48 Wistar Albino Rats (24M + 24F) were selected and divided into 4 groups. 
Each group consist of 12 animals (Male -6, and Female-6). First group treated as a 
control and other three group were treated with test drug (low, mid, high) for 28 days. 
Animals were allowed acclimatization period of 7 days to laboratory conditions prior to 
the initiation of treatment. Each animal was marked with picric acid. The females were 
nulliparous and non-pregnant. 
 
 
Groups No of Rats 
Group I  Vehicle control  12(6male,6 female) 
Group II KALLADAIPPU CHOORANAM 50 mg/kg 12 (6male,6 female) 
Group III KALLADAIPPU CHOORANAM 250 
mg/kg 
12 (6male,6female) 
Group IV KALLADAIPPU CHOORANAM 500 
mg/kg 
12(6male,6female) 
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Justification for Dose Selection: 
         As per OECD guideline three dose levels were selected for the study. They are 
low dose (50 mg/kg), mid dose dose (250 mg/kg), high dose (500 mg/kg). X is 
calculated by multiplying the therapeutic dose of human (3000mg/kg) and the body 
surface area of the rat (0.018). i.e X dose is 50 mg/kg/animal, 5X mid dose is 250 
mg/kg, 10 X high dose is 500 mg/kg. 
Preparation and Administration of Dose: 
 KALLADAIPPU CHOORANAM suspended in with water, It was administered 
to animals at the dose levels of 50, 250 and 500 mg/kg. The test substance suspensions 
were freshly prepared every two days once for 28 days. The control animals were 
administered vehicle only. The drug was administered orally by using oral gavage 
oncedaily for 28 consecutive days. 
Observations: 
Experimental animals were kept under observation throughout the course of 
study for the following: 
Body Weight: 
Weight of each rat was recorded on day 0, at weekly intervals throughout the course of 
study. 
Food and water Consumption: 
 Food and water consumed per animal was calculated for control and the treated 
dose groups.  
Clinical signs:  
All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
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Mortality: 
All animals were observed twice daily for mortality during entire course of 
study. 
Necropsy: 
All the animals were sacrificed by excessive anesthesia on day 29. Necropsy of 
all animals was carried out. 
Laboratory Investigations: 
Following laboratory investigations were carried out on day 29 in animals 
fasted over-night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Bio chemistry and potassium EDTA (1.5 mg/ml) for 
Hematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes. 
Hematological Investigations: 
Hematological parameters were determined using Haematologyanalyzer.  
Biochemical Investigations:  
Biochemical parameters were determined using auto-analyzer. 
Histopathology:  
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low, then the mid dose group will also be examined. Organs will be collected 
from all animals and preserved in 10% buffered neutral formalin for 24 h and washed 
in running water for 24 h.  The organ sliced 5 or 6µm sections and were dehydrated in 
an auto technicon and then cleared in benzene to remove absolute alcohol. Embedding 
was done by passing the cleared samples through three cups containing molten paraffin 
at 50°C and then in a cubical block of paraffin made by the “L” moulds. It was 
followed by microtome and the slides were stained withHaematoxylin-eosin red. 
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Statistical analysis:  
Findings such as body weight changes, water and food consumption, 
hematology and blood chemistry were subjected to One-way ANOVA followed by 
dunnett test using a computer software programme – Graph pad version 5.0 .All data 
were summarized in tabular form, (Table-6 to 12) 
 
RESULTS 
Repeated Dose 28- day oral toxic study ofKALLADAIPPU CHOORANAM 
Table 6: Body weight of wistar albino rats group exposed to KALLADAIPPU 
CHOORANAM 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Table 7: Water intake (ml/day) of Wistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
DOSE 
 
DAYS 
1 6 14 21 28 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 165.6±  2.76 
166.4 ± 
3.42 
167.7 ± 3.26 
169.2 ± 
3.73 
170.7 ± 1.31 
LOW DOSE 160.2 ± 2.12 
162.7 ± 
3.64 
164.4± 1.51 
165.2 ± 
1.66 
166.42± 
2.76 
MID DOSE 166.6± 1.64 
167.3 ± 
2.74 
159.4 ± 8.12 
162.1 ± 
3.36 
163.7 ± 3.11 
HIGH 
DOSE 
167.4± 6.74 
169.6 ± 
3.72 
162.6 ± 2.46 167 ± 6.81 
161.92 ± 
2.49 
P value (p)* NS NS NS NS NS 
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CONTROL 31.5 ± 
8.95 
32.0 ±6.23 28.5±6.23 29.12±8.19 31.5±3.96 
LOW 
DOSE 
21.5±3.28 21.4±3.22 21.7±3.02 21.2±3.29 24.9±3.11 
MID DOSE 26.7±4.33 26.3±2.11 27.1±2.43 28.4±2.11 32.4±2.34 
HIGH 
DOSE 
20.1±1.32 20.2±2.13 22.7±2.13 25.2±1.73 28.4±2.65 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Table 8: Food intake (gm/day) of Wistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
DOSE 
 
DAYS 
2 7 23 22 28 
CONTROL 37.12 
±5.37 
38.5±3.22 39.5±3.37 38.5±3.37 37.12±3.12 
LOW 
DOSE 
43.7±2.68 44.3±1.12 44.1±1.18 44.4±2.12 44.6±2.42 
MID DOSE 46.2±3.75 45.2±3.60 45.2±4.25 45.4±2.68 47.2±2.44 
HIGH 
DOSE 
47.2±2.34 47.2±2.64 48.6±2.66 49.2±3.20 49.0±3.62 
P value (p)* NS NS NS NS NS 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test). 
 
 
  
TOXICITY STUDY 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 138 
 
Table 9: Haematological parameters of Wistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
 
Category Control Low dose Mid dose High dose P value 
(p)* 
Haemoglobin(
g/dl) 
14.8±1.88 13.88±1.66 14.94±0.66 15.28±0.96 N.S 
Total WBC 
(×10
3   
l) 
10.91±2.59 11.25±3.73 11.48±3.91 12.20±3.17 N.S 
Neutrophils(
%) 
32.65±1.06 33.23±2.14 35.61±1.36 35.40±2.20 N.S 
lymphocyte 
(%) 
69.34±2.48 72.12±3.12 72.48±2.66 73.10±3.16 N.S 
Monocyte (%) 0.78±0.17 0.79±0.09 0.82±0.03 0.84±0.06 N.S 
Eosinohil(%) 0.64±0.09 0.68±0.02 0.70±0.06 0.72±0.04 N.S 
Platelets 
cells10
3
/µl 
687.17±8.76 702.71±8.16 725.18±9.0 726.16±9.74 N.S 
Total RBC 
10
6
/µl 
7.99±0.12 7.82±0.57 8.82±0.59 8.38±0.72 N.S 
PCV% 37.79±0.6 43.35±1.13 45.2±1.68 46.82±2.54 N.S 
MCHC g/dL 33.6±2.23 35.09±1.29 35.98±1.22 36.03±1.24 N.S 
MCV fL(µm
3
) 49.17±3.64 50.20±1.22 52.28±1.24 53.24±1.44 N.S 
 
N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
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Table 10: Biochemical Parameters of Wistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
BIOCHEMICAL 
PARAMETERS 
CONTRO
L 
LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
P 
Value 
(p)* 
GLUCOSE (R) (mg/dl) 75.45±13.4 78.16±8.44 
78.26±11.
20 
78.42±11.6 N.S 
T.CHOLOSTEROL(m
g/dl) 
115.26±
1.83 
115.45±1.8
3 
116.42±1.
78 
116.22±1.7
3 
N.S 
TRIGLY(mg/dl) 45.35±1.48 46.32±1.48 
44.58±1.3
0 
45.66±1.33
* 
N.S 
LDL 73.81±2.13 71.24±2.14 72.8±2.14 71.64±4.32 NS 
VLDL 14.2±2.44 15.42±4.64 
15.44±6.6
4 
15.64±4.36 NS 
HDL 25.66±6.88 26.86±2.24 
26.68±4.6
6 
31.78±2.22 NS 
Ratio 1(T.CHO/HDL) 3.42±2.44 4.16±3.14 4.34±8.44 4.46±2.22 NS 
Ratio 2(LDL/HDL) 
 
3.83±4.22 2.84±2.22 2.86±2.20 2.96±6.02 NS 
Albumin(g/dL) 2.63±0.17 3.43±0.12 3.14±2.02 3.24±6.86 NS 
  
NS- Not Significant,**(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table 11: Renal function test of ofWistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
PARAMETERS 
CONTRO
L 
LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
P Value 
(p)* 
UREA (mg/dl) 
13.35±0.9
9 
14.31±0.16 
13.06±1.0
8 
13.48±1.12 N.S 
CREATININE(m
g/dl) 
0.28±0.08 0.36±0.06 0.52±0.04 0.66±0.02 N.S 
BUN(mg/dL) 
15.02±0.1
0 
16.10±0.60 
16.22±0.4
4 
18.10±2.12 NS 
URIC 
ACID(mg/dl) 
5.17±0.35 5.31±0.43 
5.72±1.25
* 
5.58±0.23 S 
 
 NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Table 12: Liver Function Test of ofWistar albino rats group exposed to 
KALLADAIPPU CHOORANAM 
PARAMETERS CONTROL 
LOW 
DOSE 
MID 
DOSE 
HIGH 
DOSE 
P 
Value 
(p)*  
T 
BILIRUBIN(mg/dl
). 
0.45±0.07 0.53±0.06 0.51±0.08 0.48±0.05 N.S 
SGOT/AST(U/L) 78.95±1.39 
78.35±0.5
1 
76.01±1.5
3 
81.55±1.03 N.S 
SGPT/ALT(U/L) 30.23±1.28 
30.91±1.5
9 
28.34±1.4
8 
34.32±0.68 N.S 
ALP(U/L) 142.25±8.70 142±16.17 
147.16±24
.07* 
149.33±14.6
5* 
S 
T.PROTEIN(g/dL) 5.31±0.38 6.48±0.34 7.01±0.23 7.53±0.46 N.S 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D (One way 
ANOVA followed by Dunnett’s test) 
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HISTO PATHOLOGY 
CONTROL GROUP 
         Kidney                                          Liver                    Spleen 
 
 
 
 
TEST GROUP (HIGH DOSE) 
         Kidney                                      Liver                    Spleen 
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                   AN EVALUATION OF THE SIDDHA DRUG KALLADAIPPU 
CHOORANAM (KC) FOR ITS LITHOTRIPTIC ACTIVITY IN  
WISTAR  ALBINO RATS. 
 
ANIMAL STUDIES 
Experimental Animals: 
Adult Female Wistar rats weighing 200-250gms were used for this study. The 
inbredanimals were procured from the animal house of King institute, Guindy, Chennai. 
Theywere housed six per cage under standard laboratory conditions at a room temperatureat 
22±20C with 12 hr light/dark cycle. The animals were provided with pellet chow andwater. 
Animals were acclimatized to laboratory conditions one week prior to initiationof 
experiments. Ethical committee clearance was obtained from IAEC (Institutional Animal 
Ethics Committee) of CPCSEA (Committee for the Purpose of Control andSupervision of 
Experiments on Animals). 
IAEC Reference no: 
IAEC/LI/16/CLBMCP/2017 
EXPERIMENTAL DESIGN 
Ethylene glycol induced hyperoxaluria method was used to assess the anti-urolithiatic 
activity in albino wistar male rats.  
Animals were divided into 5 groups of 6 animals each. All the experimental animals 
except normal control received ethylene glycol (0.75%) in drinking water for a period of 28 
days and a single dose of sodium oxalate injection (35 mg/kg, i.p) on 14th day for induction 
of urolithiasis. Rat belongs to treatment group co-administered with SP at the dose of 10 and 
200  mg/kg b.wt, p.o from 1st to 28st day, Animals belonging to standard group received 
cystone 500 mg/kg, p.o 
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GROUPING OF ANIMALS 
Group I: Control group rats received normal saline   
Group II: Administered with ethylene glycol (0.75%) + Sodium oxalate injection (35mg/kg 
,i.p)  
Group III: Administered with ethylene glycol and treated with KC at 100 mg/kg, p.o  
Group IV: Administered with ethylene glycol and treated with KC at 200 mg/kg, p.o  
Group V: Administered with ethylene glycol and treated with cystone 500 mg/kg, p.o  
24  hour  urine  samples  will  be  collected  on  14th  and  24thday  by  housing  rats 
at  individual  metabolic  cages  using sodium  azide  as  preservative. Parameters such  as  
volume,  will  be  noted immediately  after  urine  sample  collection  and  stored  at  -8
o
  C,  
for  further  electrolyte  estimation. 
Collection and analysis of urine  
All animals were kept in individual metabolic cages and 24 hr urine samples were 
collected on 14th, and 28th day of calculi induction treatment.  The volume and calcium 
content of urine were measured.  Estimation done usingauto analyzer. Urine was analyzed for 
oxalate, magnesium, Calcium, phosphate, uric acid,and creatinine. 
Effect of KALLADAIPPU CHOORANAM  on Urine volume in ml output on Day 0, 
14 and 28th Day  
 
Days Group I Group II Group III Group IV Group V 
0 7.72±1.24 7.54±2.12 7.82±2.21 7.66±2.42 8.52±1.56 
14 7.79±3.22 6.89±1.22 8.32±1.86 9.10±1.32 11.20±1.66 
28 8.30±4.10 6.28±2.11 8.58±1.24 10.22±1.46 11.90±1.82 
Values are expressed as mean ± SEM, Values were calculated by using One Way Anova 
PHARMACOLOGICAL STUDY 
 
Kalladaippu Chooranam for Vatha Kalladaippu Page 144 
 
U r in e  v o lu m e
D a y s
V
o
lu
m
e
 i
n
 m
l
0
1
4
2
8
0
5
1 0
1 5
gp1
gp2
gp3
gp4
gp5
 
 
Effect of  KALLADAIPPU CHOORANAM  on urine analysis on 14
th
 day 
Group  Mg+ 
(mg/dl) 
Ca+ 
(mg/dl) 
Uric acid  
(mg/dl) 
Creatinine  
(mg/dl) 
Oxalate  
(mg/dl) 
Phosphate 
(mg/dl) 
Group I 4.35±.64 5.69±0.46 8.19±1.45 0.82±0.12 16.54±2.22 36.10±1.12 
Group II 1.10±4.62 26.12±1.42 16.44±1.72 1.61±0.22 30.24±2.54 76.2±2.84 
Group III 2.65±1.04 18.76±1.32 9.86±2.04 0.89±3.24 23.21±1.42 47.20±2.12 
Group IV 2.62±1.24 16.85±1.24 9.96±1.10 0.86±0.09 24.40±1.68 34.20±1.12 
Group V 3.32±1.46 15.42±1.20 8.89±3.04 0.79±1.42 19.18±1.10 34.89±1.08 
 
Values are expressed as mean ± SEM, Values were calculated by using One Way Anova 
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Effect of  KALLADAIPPU CHOORANAM  on urine analysis on 28th day 
Group  Mg+ 
(mg/dl) 
Ca+ 
(mg/dl) 
Uric acid  
(mg/dl) 
Creatinine  
(mg/dl) 
Oxalate  
(mg/dl) 
Phosphate  
(mg/dl) 
Group I 4.20±0.56 7.6±0.24 4.1±1.54 0.87±0.32 18.64±1.12 30.10±1.56 
Group II 1.88±1.32 28.14±1.22 19.42±1.52 1.61±0.42 56.24±1.64 84.2±1.62 
Group III 2.02±1.20 19.16±1.22 8.36±1.14 1.13±2.12 27.42±1.20 48.22±1.10 
Group IV 3.65±1.10 11.64±1.14 7.86±0.64 1.02±0.24 22.32±1.42 44.20±2.10 
Group V 3.12±1.41 09.12±1.08 7.19±3.04 0.80±1.36 18.26±1.21 32.60±1.04 
Values are expressed as mean ± SEM, Values were calculated by using One Way Anova 
 
 
Effect of CK on uri e analysis on 14
th
 day 
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E ffe c t o f  V K  o n  u r in e  a n a ly s is  o n  2 8 th  d a y
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Effect of  KALLADAIPPU CHOORANAM  on serum analysis on 28th day 
Group  Mg+ 
(mg/dl) 
Ca+ 
(mg/dl) 
Uric acid  
(mg/dl) 
Creatinine  
(mg/dl) 
Oxalate  
(mg/dl) 
Phosphate  
(mg/dl) 
Group I 4.96±1.14 10.62±1.18 3.24±1.15 0.48±0.21 6.54±1.62 13.10±1.28 
Group II 2.01±1.22 19.12±2.44 09.24±1.12 1.31±0.20 13.64±1.44 31.2±1.48 
Group III 3.98±1.04 13.76±1.02 4.86±1.24 0.79±1.14 09.21±1.32 27.20±1.20 
Group IV 3.86±0.24 12.85±1.40 3.86±1.24 0.56±0.12 09.40±1.72 20.10±1.10 
Group V 4.52±1.48 09.12±0.20 3.09±1.02 0.49±1.04 7.08±1.08 14.89±1.28 
Values are expressed as mean ± SEM, Values were calculated by using One Way Anova 
 
. 
Effect of CK on u i alysis on 28
th
 day 
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E ffe c t o f  V K  o n  s e ru m  a n a ly s is  o n  2 8 th  d a y
G ro u p s
m
g
/d
l
G
rp
1
G
rp
2
G
rp
3
G
rp
4
G
rp
5
0
1 0
2 0
3 0
4 0
M g+
C a +
U .a c id
C re a tin in e
O xa la te
P hospha te
 
CONCLUSION; 
In conclusion, the results indicated that the administration of Kalladaippu Chooranam 
to rats with ethylene glycol-induced urolithiasis reduced the growth of the urinary stone and 
hastened the process of dissolving the formed stones. These effects could conclude the 
lithotriptic activity of Kalladaippu Chooranam was less the effect of standard drug. 
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BIO-CHEMICAL ANALYSIS OF TRIAL MEDICINE 
Preparation of Sodium Carbonate extract: 
2 gm of the sample drug is mixed 5 gm of Sodium carbonate and taken in a 
100 ml beaker and 20 ml of distilled water is added. The solution is boiled for 10 
minutes, cooled and then filtered. The filtrate is called sodium carbonate extract. 
S.No EXPERIMENT OBSERVATION INFERENCE 
I                                    TEST FOR ACID RADICALS 
1a Test for Sulphate 
2 ml of the above prepared 
extract is taken in a test tube. To 
this add 2ml of 4% Ammonium 
oxalate solution. 
Absence of 
White Precipitate 
Absent 
b 2ml of extract is added with 2ml 
of dilute hydrochloric acid until 
the effervescence ceases off. 
Then 2ml barium chloride 
solution is added. 
Absence of 
White Precipitate 
Absent 
2 Test for Chloride: 
2ml of extract is added with 
dilute nitric acid till the 
effervescence ceases. Then 2ml 
of silver nitrate solution is 
added. 
white precipitate 
obtained 
Present 
3 Test for Phosphate 
2ml of the extract is treated with  
2 ml of Ammonium molybdate 
solution and 2ml of 
concentrated nitric acid. 
Yellow precipitate 
obtained 
Present. 
4 Test for Carbonate: 
2ml of the extract is treated with 
2ml of magnesium sulphate 
solution. 
Absence of white 
precipitate 
Absent 
5 Test for Sulphide: 
1 gm of the substance is treated 
with 2ml of concentrated Hcl. 
Absence of Rotten 
egg smelling 
Present 
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6 Test for Nitrate: 
1gm of the substance is heated 
with copper turnings and 
concentrated sulphuric acid and 
viewed the test tube vertically 
down. 
Absence of reddish 
brown gas. 
Absent 
 
7a Test for Fluoride and oxalate 
2ml of the extract is added with 
2ml of dilute acetic acid and 2ml 
of calcium chloride solution and 
heated. 
Absence of white 
precipitate 
Absent 
b 5 drops of clear solution is added 
with 2ml of diluted sulphuric acid 
and slightly warmed to this, 1 ml 
of dilute potassium permanganate 
solution is added. 
KMNO4 solution 
Discolourisation 
obtained 
Absent 
8 Test for Nitrite 
3 drops of the extract is placed on 
a filter paper. On that, 2 drops of 
Acetic Acid and 2 drops of 
Benzidine solution is placed. 
Absence of 
yellowish red colour 
Absent 
9 Test for Borate 
2 pinches of the substance is 
made into paste by using 
Sulphuric acid and Alcohol 
(95%) and introduced into the 
blue flame. 
Absence of Green 
tinged flame 
Absent 
II TEST FOR BASIC RADICALS 
10 Test for lead 
2 ml of the extract is added with 
2 ml of Potassium iodide 
solution. 
Absence of Yellow 
precipitate 
Absent 
11a Test for Copper 
One pinch of substance is made 
into paste with concentrated 
Hydrochloric acid in a watch 
glass and introduced into the non 
luminous part of the flame. 
Absence of Bluish 
green coloured 
flame. 
Absent 
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b 2ml of the extract is added with 
excess of Ammonia solution 
 
Absence of deep 
blue 
Absent 
12 Test for Aluminium 
To the 2 ml of extract. Sodium 
Hydroxide solution is added in 
drops to excess 
Absence of White 
Precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
Solution is added. 
Absence of Blood 
red colour 
Absent 
b To the 2 ml of extract, 2 ml of 
Ammonium Thiocyanate 
solution and 2 ml of 
concentrated Nitric Acid is 
added. 
Blood red colour 
obtained 
Present 
14 Test for Zinc 
To the 2 ml of extract Sodium 
Hydroxide solution is added in 
drops to excess. 
 
Absence of White 
precipitate. 
Absent 
15 Test for Calcium 
2 ml of the extract is added with 
2 ml of 4% Ammonium Oxalate 
solution. 
Absence of White 
precipitate. 
Absent 
16 Test for Magnesium 
2ml of extract, Sodium 
Hydroxide solution is added in 
drops to excess. 
Absence of White 
precipitate. 
Absent 
17 Test for Ammonium 
2 ml of extract few ml of 
Nessler’s Reagent and excess of 
Sodium Hydroxide solution are 
added. 
Absence of 
Reddish brown 
Precipitate 
Absent 
18 Test for Potassium 
A pinch of substance is treated 
with 2 ml of Sodium Nitrite 
solution and then treated with 2 
ml of Cobal Nitrate in 30% 
glacial Acetic acid. 
Absence of Yellow 
precipitate 
 
Absent 
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19 Test for Sodium 
2 pinches of the substance is 
made into paste by using 
Hydrochloric acid and 
introduced into the blue flame. 
Absence of Yellow 
colour flame 
Absent 
20 Test for Mercury 
2 ml of the extract is treated with 
2 ml of Sodium Hydroxide 
solution. 
Absence of yellow 
precipitate 
Absent 
21 Test for Arsenic 
2 ml of extract is treated with 2 
ml of silver Nitrate solution. 
Absence of 
Yellow precipitate 
Absent 
22 Test for Starch 
2ml of extract is treated with 
weak iodine solution 
Absence of 
Blue colour 
Absent 
23 Test of reducing Sugar 
5ml of Benedicts qualitative 
solution is taken in a test tube 
and allowed to boil for 2 minutes 
and added 10 drops of the extract 
and again boiled for 2 minutes. 
The colour changes are noted. 
Absence of Green 
colour 
Absent 
24 Test of the alkaloids 
2ml of the extract is treated with 
2ml of potassium lodide 
solution. 
Absence of 
Red colour 
Absent 
25 Test of the proteins 
2ml of the extract is treated with 
2ml of 5% NaOH, mix well and 
add 2 drops of copper sulphate 
solution. 
Absence of 
Violet colour 
Absent 
 
RESULTS:  
 The given sample (KalladaippuChooranam) contains  
Acid Radicals: Chloride, Phosphate, Sulphide  
Basic Radical: Iron. 
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BIO STATISTICAL ANALYSIS 
CLINICAL PROGNOSIS 
Treatment for Vadha Kalladaippu: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
 
S. 
No 
Signs&Symptoms 
Before Treatment After Treatment 
n% n% 
1. Flank pain 40(100) 7(17.5)** 
2. Nausea 2(5) 0(0)* 
3. Vomiting 10(25) 0(0)** 
4. Burning Micturition 20(50) 3(7.5)** 
5. Dysuria 3(7.5) 0(0)* 
6. Oliguria 12(30) 0(0)** 
7. Fever 5(12.5) 0(0)* 
McNemar test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all symptoms.So there is significant reducing 
of symptoms among the patients for the treatment ofVadhaKalladaippu.Hence it is 
concluded that the treatment was effectiveand significant. 
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Treatment for VadhaKalladaippu: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
 
DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
S. 
No 
Side Before Treatment After Treatment 
n% n% 
1. Rt – Kidney 10(25) 6(15)* 
2. Lt - Kidney 9(22.5) 4(10)* 
3. Bilateral 20(50) 18(45)* 
4. Ureteral 1(2.5) 0(0)* 
 
McNemar  test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in sides.So there is a significant changes 
indistribution of calculi based on location except ureteral.Hence it is concluded 
that the treatment was effectiveand significant. 
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CONSENT FORM 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “KALLADAIPPU CHOORANAM” IN THE 
TREATMENT OF 
“VATHA KALLADAIPPU” (UROLITHIASIS) 
 
 INFORMED CONSENT FORM 
 
“I have read the foregoing information. I have had the opportunity to ask 
questions about it and any questions I have asked have been answered to my 
satisfaction. 
            I   consent voluntarily to participate in this study and understand that I have 
the   right to withdraw from the study at any time without in any way it affecting my 
further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date:    
Station:                                                                                  
Signature of participant:  
 
Signature of the Guide:   Signature of the Investigator:   
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muR Á¤j kU¤Jt¡ fšÿç, br‹id - 106 
m¿P® m©zh kU¤Jtkid, br‹id 
thj fšyil¥ò nehŒ¡fhd Á¤j kUªÂ‹ (fšyil¥òNuz«) 
gçfç¥ò¤ Âwid¡ f©l¿Í« kU¤Jt MŒé‰fhd jftš got«. 
 
x¥òjš got« 
MŒthsuhš rh‹wë¡f¥g£lJ 
 eh‹ Ïªj MŒit F¿¤j mid¤J égu§fisÍ« nehahë¡F òçÍ« 
tifæš vL¤Jiu¤nj‹ vd cWÂaS¡»nw‹. 
njÂ:          ifbah¥g«: 
Ïl«:          bga®:  
nehahëæ‹ x¥òjš 
 v‹ål« Ïªj kU¤Jt MŒé‹ fhuz¤ijÍ«, kUªÂ‹ j‹ik k‰W« 
kU¤Jt têKiw g‰¿Í«, bjhl®ªJ vdJ clš Ïa¡f¤ij f©fhâ¡fÎ«, 
mjid ghJfh¡fÎ« ga‹gL« kU¤Jt MŒÎ¡Tl gçnrhjidfŸ g‰¿ 
ÂU¥Â më¡F« tifæš MŒÎ kU¤Jtuhš és¡»¡ Tw¥g£lJ.  
 eh‹ Ïªj kU¤Jt MŒé‹ nghJ, fhuz« vJÎ« Twhkš, v¥bghGJ 
nt©LkhdY« Ïªj MŒéèUªJ v‹id éLé¤J bfhŸS« cçikia 
bjçªÂU¡»nw‹. eh‹ v‹Dila RjªÂukhf nj®Î brŒÍ« cçikia¡ 
bfh©L thj fšyil¥ò nehŒ¡fhd fšyil¥ò Nuz« kUªÂ‹ gçfç¥ò¤ 
Âwid¡ f©l¿Í« kU¤Jt MŒé‰F v‹id c£gL¤j x¥òjš më¡»nw‹.  
        ifbah¥g«: 
njÂ:        bga®: 
Ïl«: 
  
        rh£Á¡fhu® 
ifbah¥g«: 
njÂ:        bga®: 
Ïl«: 
cwÎKiw:  
 
 
 
Jiw¤jiyt® ifbah¥g«:    MuhŒ¢Áahs®  
ifbah¥g«: 
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CASE SHEET PROFORMA FOR VATHA KALLADAIPPU  
GOVT.SIDDHA MEDICAL COLLEGE&HOSPITAL, CHENNAI-106 
 POST GRADUATE DEPARTMENT BRANCH –I MARUTHUVAM 
Duration: 2015-2018 
OP No / IP No  :    Occupation  : 
Ward No  :    Income  : 
Bed No  :    Nationality  : 
Name   :    Religion  : 
Age   :    D.O.A   : 
Sex   :    D.O.D   : 
Address  :    Diagnosis  : 
 
1. Complaints and duration  : 
 
2. History of present illness  : 
 
3. History of past illness  : 
 
4. Personal history   : 
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5. Occupational history  : 
 
6. Menstrual history   : 
 
7. Personal Habits   : Veg/non veg/smoker/Alcoholic/Tobacco chewer 
 
8. Family History   : 
 
GENERAL EXAMINATION  
Patient consciousness   : 
Body Built    : 
Nourishment    : 
Anemia    : 
Jaundice    : 
Cyanosis    : 
Clubbing    : 
JVP     : 
Tracheal deviation   : 
Pedal oedema    : 
Lymph adenopathy   : 
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VITAL SIGNS 
Body Temp    : 
Pulse     : 
Respiratory rate   : 
Blood Pressure   : 
Weight    : 
SIDDHA ASPECT 
NILAM 
Kurinji                                               : 
Mullai                                               : 
Marutham                                         : 
Neithal                                              : 
Palai                                                  : 
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PARUVA KALAM 
Kaar   : 
Koothir  : 
Munpani  : 
Pinpani  : 
Elavenil  : 
Muduenil  : 
YAAKKAI (Udal) 
Vatham                       : 
Pitham                        : 
Kabham                      : 
Kalappu                      : 
 
GUNAM 
Saththuvam                : 
Rajotham                    : 
Thamasam                  : 
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PORI/PULANGAL 
(SENSORY ORGANS) 
Mei –Sensation   : 
Vaai – Taste    : 
Kan – Vision     : 
Mooku - Smell   : 
Sevi – Hearing   : 
KANMENTHRIYAM/KANNMA VIDAYAM [MOTOR ORGANS] 
Kai- Dhaanam    : 
Kaal-Kamanam   : 
Vaai-Vasanam   : 
Eruvaai- Visarkkam   : 
Karuvaai-Aanantham   : 
UTHKAAYA ATHAKAAYAM 
Puyam[forearm]   : 
Sayam[arm]    : 
Kaal[leg]    : 
Paaatham[feet]   : 
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UYIR THATHUKKAL 
A.VATHAM 
 Piranan   : 
 Abanan   : 
 Viyanan   : 
 Udanan   : 
 Samanan   : 
 Nagan    : 
 Koorman   : 
 Kirukaran   : 
Devathathan   : 
Thananjeyan   : 
B.PITHAM 
Anarpitham   : 
Ranjagapitham  : 
Saathagapitham  : 
Pirrasagapitham  : 
Alosagapitham  : 
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C.KAPAM 
Avalambagam   : 
Kilethagam   :  
Pothagam   : 
Tharpagam   : 
Santhigam   : 
UDALTHAATHUKKAL 
Saaram   : 
Senner    : 
Oon    : 
Kozhuppu   : 
Enbu    : 
Moolai    : 
Sukkilam/Suronitham  : 
ENVAGAI THERVUGAL 
1.Naa    : 
2.Niram   : 
3.Mozhi   : 
4.Vizhi   : 
5.Sparisam   : 
6.Malam   : 
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7.Moothiram 
a)NeerKuri  : 
 b)NeiKuri  : 
8.Naadi   : 
MALAM 
 Niram    : 
 Edai    : 
 Erugal    : 
 Elagal    : 
MOOTHIRAM 
 1.Neerkuri 
  Niram   : 
  Manam  : 
  Edai   : 
  Nurai   : 
  Enjal   : 
 2.Neikuri 
 
MODERN ASPECT 
 
Sytemic Examination  
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 Inspection   : 
 Palpation   : 
                    Renal angle                     : 
                    Tenderness                      : Present/Absent  
                    Radiation                         :      
 Percussion   : 
 Auscultation   : 
 
     Others Systems  
 Cardio Vascular System : 
 Respiratory system  : 
 Central nervous system : 
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CLINICAL SIGN AND SYMPTOMS OF VATHAKALLADAIPPU 
 
 
S.No 
 
Symptoms 
 
Before 
Treatment 
After Treatment 
10
th
 day 20
th
 day 30
th
 
day 
40
th
 
day 
1 Pain 
 Site 
 Radiation 
 Character 
     
2 Nausea      
3 Vomiting      
4 Burning Micturition      
5 Dysuria      
6 Oliguria      
7 Haematuria      
8 Retention      
9 Fever      
10 Frequency of 
Micturition 
     
 
 INVESTIGATION 
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1. BLOOD 
  TC, DC, ESR 
  Bleeding time, Clotting time 
  Blood sugar 
  Blood urea 
  Serum cholesterol 
Serum calcium  
  VDRL 
2. URINE 
  Colour 
  Turbidity 
  Albumin 
  Sugar 
  Deposits 
 Epithelial cells 
 RBC’s 
 Pus cells 
Casts 
Specific gravity 
Urine culture and sensitivity 
3. USG Abdomen and Pelvis 
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CASE SUMMARY 
DIAGNOSIS 
VATHA KALLADAIPPU (UROLITHIASIS) 
TRIAL MEDICINE: 
 KALLADAIPPUCHOORANAM 
Dose: 1 Gram 
Adjuvant : Honey 
Duration of Treatment: 48 days 
DO’S : 
1. Drink 4-5 ltrs of water per day. 
2. Drinking tender coconut/ barley water lemon juice, raddish juice. 
3. The following vegetables can be taken in the diet : 
i. Raddish 
ii. Lady’s finger 
iii. Plantain pith 
iv. Mint leaves 
v. Bottle guard. 
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DON’T’S: 
1. Avoid cabbage, cauliflower, tomato seeds, mushroom. 
2. Avoid milk and its products. 
3. Avoid chicken, fish and other sea foods 
4. Avoid drinking fluoride containing water. 
Prognosis 
 
 
 
Medical Officer Signature:       HOD 
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